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ABSTRACT 
Salivary gland inflammation is a hallmark of Sjögren’s syndrome (SS), a common 
autoimmune disease characterized by lymphocytic infiltration and the consequent 
impairment of the salivary gland and loss of saliva secretion, predominantly in women. 
The current therapeutic management of SS is relatively ineffective and does not address 
the underlying inflammatory processes contributing to the pathology of SS. In this study, 
two novel therapeutic approaches were evaluated to limit salivary gland inflammation 
and improve secretory function, i.e., antagonism of the P2X7 nucleotide receptor 
(P2X7R), which prevents salivary gland inflammation and activation of the P2Y2 
nucleotide receptor (P2Y2R) which stimulates the regeneration of damaged salivary 
glands. The P2X7R is an ATP-gated non-selective cation channel that regulates 
inflammatory responses in cells and tissues, including salivary gland epithelium. The 
P2X7R contributes to the pathology of a variety of inflammatory diseases, including 
rheumatoid arthritis and inflammatory bowel disease. In immune cells, P2X7R activation 
induces the production of pro-inflammatory cytokines, including IL-1β and IL-18, by 
inducing the oligomerization of the multiprotein complex NLRP3-type inflammasome. 
This study (Chapter II) sheds light on the role of the P2X7R in salivary gland 
inflammation and hyposalivation. Our results show that in primary mouse submandibular 
gland (SMG) epithelial cells, P2X7R activation induces the assembly of the NLRP3 
inflammasome and the maturation and release of IL-1β, responses that are absent in SMG 
cells isolated from mice devoid of P2X7Rs (P2X7R
-/-
). P2X7R-mediated IL-1β release in 
SMG epithelial cells is dependent on downhill transmembrane Na
+
 and/or K
+
 fluxes, the 
activation of heat shock protein 90 (HSP90), a protein required for the activation and 
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stabilization of the NLRP3 inflammasome, and the generation of mitochondrial ROS. In 
vivo administration of the P2X7R antagonist A438079 in the CD28
-/-, IFNγ-/-, NOD.H-2h4 
mouse model of salivary gland exocrinopathy ameliorated salivary gland inflammation 
and enhanced carbachol-induced saliva secretion. These findings demonstrate that 
P2X7R antagonism in vivo represents a promising therapeutic strategy to limit salivary 
gland inflammation and improve secretory function. The P2Y2R, a G protein-coupled 
receptor equipotently activated by ATP and UTP, is upregulated in a variety of tissues, 
including salivary gland epithelium, in response to injury or stress and is proposed to play 
a role in tissue regeneration. The results indicated that P2Y2R activation with UTP 
enhances the migration, aggregation and self-organization of dispersed salivary epithelial 
cells forming spheres that display characteristics similar to differentiated acini in salivary 
glands. 
One of the consequences of the chronic inflammatory disease SS is the fibrosis of 
the salivary gland. The role of transforming growth factor- (TGF-β) is well established 
in the fibrosis and regeneration of various organs, including the liver, lung and kidney. In 
this study, results with a submandibular gland (SMG) duct ligation-induced mouse model 
of fibrosis indicated that 7 days of SMG duct ligation resulted in upregulation of TGF-β 
signaling components which correlated with the upregulation of the fibrosis markers 
collagen 1 and fibronectin, responses that were inhibited by administration of the TGF-β 
receptor 1 inhibitors. These results suggest that TGF-β signaling contributes to duct 
ligation-induced changes in salivary epithelium that correlate with glandular fibrosis. 
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Chapter I 
Introduction 
Salivary gland is an exocrine gland whose function is to produce saliva
1
. 
Salivary glands are classified into major and minor salivary glands according to their 
size. There are three pairs of major salivary glands, namely the parotid, submandibular 
and sublingual glands. Also, there are many minor salivary glands lining the oral 
cavity
1
. Saliva plays a very important role in helping gustatory buds perceive taste, and 
help protect and lubricate oral tissues, thereby maintaining the integrity of tooth enamel 
in addition to its roles in digestion and as a bactericide
2
. Accordingly, salivary gland 
dysfunction greatly diminishes the quality of life of patients causing hyposalivation, dry 
mouth, oral bacterial and yeast infections and speech problems
2
. One of the major 
causes of salivary gland dysfunction and hyposalivation is Sjögren’s syndrome (SS), 
the major focus of this study, which is an autoimmune inflammatory disease that affects 
exocrine glands, particularly salivary and lacrimal glands
3
. Another cause of salivary 
gland dysfunction is the unintended secondary effect of radiotherapy in head and neck 
cancer patients
4
 
1.1 Sjögren’s syndrome  
Sjögren’s syndrome (SS) is a chronic autoimmune inflammatory disorder that 
affects exocrine glands, particularly lacrimal and salivary glands
3
. One of the hallmarks 
of (SS) is the mononuclear cell infiltration of salivary glands, mainly T- and B-cells
3
, 
dendritic cells
5
 and macrophages
6
. The infiltrating cells produce pro-inflammatory 
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cytokines, e.g., IL-18, IL-22 and IFN-γ in addition to IL-1β and IL-6 produced by 
immune cells or salivary gland epithelial cells
3, 7, 8
.  Another characteristic of (SS) is the 
production of high levels of immunoglobulins and the autoantibodies anti-Ro and anti-
La (against ribonucleoprotein complexes)
9
, anti-α-fodrin10-12 (against a membrane 
associated cytoskeletal protein), anti-muscarinic receptor-3, that inhibits saliva 
production and aquaporin translocation to the plasma membrane
13, 14
, and anti-RF 
(rheumatoid factor)
15
. It has been reported that autoantibodies purified from the serum 
of SS patients activate the intrinsic and extrinsic apoptotic pathways in the A-253 
salivary gland cell line
16
. The inflammatory responses together with apoptosis 
activation lead to destruction of the salivary gland and consequently salivary gland 
dysfunction and hyposalivation
17
.  
1.1.1Etiology of SS 
 The etiology of SS is currently unclear, although some potential contributing 
factors are described below. 
1.1.1.1 Genetic factors 
A genetic predisposition was suggested to influence the susceptibility and 
initiation of SS. The prevalence of some major histocompatibility complex (HLA) 
alleles, e.g., HLA-DR3, was reported and correlated with the production of the 
autoantibodies anti-Ro and anti-La
18
. Also, in SS patients, single nucleotide 
polymorphisms were seen in the genes for IFN-γ regulating factor-519, required for 
IFN-γ synthesis, and BAFF20, a transcription factor responsible for B-cell 
differentiation and activation. Moreover, the low serotonin levels in SS patients were 
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shown to result from polymorphisms in the serotonin reporter gene (5-HTT), where 
certain variants of the 5-HTT are repeatedly seen in SS patients
21
. 
1.1.1.2 Epigenetics 
In addition to genetic factors, epigenetic factors, including defective DNA 
methylation, also contribute to SS etiology. The dysregulation of methylation of IFN-
induced genes was linked to seropositive SS patients
22
. Also, screening of genome wide 
alterations in DNA methylation in SS patients showed that changes occur mainly in 
blood B-cells rather than blood T-cells
23
. Similarly, in systemic lupus erythematous, a 
systemic autoimmune rheumatic disease, dysregulation of T-cell methylation patterns 
was reported
24
. Interestingly, in salivary glands of SS patients, methylating enzymes 
were upregulated as compared to healthy controls which could be a defense mechanism 
to counteract the deleterious increased expression of other inflammatory genes, such as 
the long interspersed nuclear element 1 (LINE-1) gene that activates the type I IFN 
pathway, a key inflammatory response in both SS and systemic lupus erythematous
25
. 
Additionally, it was recently reported that variants of the methylene-tetrahydrofolate 
reductase (MTHFR) gene contribute to the development of non-Hodgkin lymphoma in 
SS patients as a result of the dysregulation of DNA methylation
26
. 
1.1.1.3 Hormonal factors 
The prevalence ratio of SS in females to males is 10:1, and development of the 
disease in females occurs around the menopause phase, suggesting a role for hormonal 
factors in the etiology of SS. This was addressed in different studies showing that SS 
patients acquire reduced expression of androgens, in particular dihydrotestosterone, 
which is required for the synthesis of estrogen
27
. In addition, mouse models lacking 
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aromatase that converts androgen to estrogen or those undergoing ovariectomy showed 
extensive lymphocytic infiltrates, in both lacrimal and salivary glands
28
. 
1.1.1.4 Environmental factors 
Among the environmental factors, viruses and stress are reported to contribute 
to SS pathology. Several viruses, including Epstein-Barr virus, human herpes virus 6 
and hepatitis C virus, were found to induce type 1 IFN inflammatory responses, but no 
clear cut relationship with SS has been identified
29, 30
. On the other hand, a stressful life 
has been suggested to trigger SS in susceptible patients
31
.  
1.1.2 Current treatments for SS 
The current therapeutic management of SS is through the stimulation of saliva 
or tear flow in residual salivary or lacrimal epithelium by administration of muscarinic 
receptor agonists (i.e., pilocarpine or cevimeline)
32
, INF-α33 or artificial tears34. The 
need for alternative treatments that address the underlying inflammatory processes in 
SS is a necessity and could be achieved through antagonizing the P2X7 purinergic 
receptor for ATP, which is a putative anti-inflammatory treatment for a variety of 
inflammatory diseases
35, 36
. 
1.2 Epithelial cells as antigen-presenting cells 
There are increasing lines of evidence that epithelial cells play a crucial 
immunological role in addition to being the physical barrier against infections. 
Different types of epithelial cells are reported to act as nonprofessional antigen-
presenting cells under pathological conditions. For example, esophageal epithelial cells 
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contribute to the pathology of eosinophilic esophagitis by acting as nonprofessional 
antigen-presenting cells that present antigens via major histocompatibility complex 
class II (MHC II) to activate THelper (TH) cells
37
. Also, primary colon epithelial cells 
isolated from colitic IL-2
-/-
 mice showed higher levels of uptake and presentation of 
antigens by MHC II to CD4
+
 T cells compared to normal non-inflamed mice
38
. 
Furthermore, intestinal epithelial cells induce T cell activation upon presentation of 
ovalbumin (OVA) antigen by MHC ll
39
.  
The inflammatory conditions surrounding salivary gland epithelial cells 
(SGECs) in SS are believed to result in their activation, inducing “autoimmune 
epithelitis”, where SGECs attract lymphocytes and modulate immune responses, hence, 
participating actively in the pathogenesis of SS
40-42
. The epithelial cells from SS 
patients were reported to have higher constitutive expression (compared to non-disease 
controls) of several immunoactive molecules, e.g., major histocompatibility complex 
(MHC I and II)
43
, costimulatory molecules (CD80 and CD86)
43
, which are ligands for 
CD28 required for T cell activation
44, 45
, adhesion molecules (e.g., E-selectin, ICAM-1 
and VCAM) required for immune cell homing and apoptotic molecules (e.g., Fas and 
Fas L)
41
. Activated SGECs also produce B cell activating factor (BAFF)
46
 responsible 
for B cell survival, maturation and differentiation, and chemokines and pro-
inflammatory cytokines (e.g., IL-1, IL-18, IL-6 and TNF-α)7. The aberrant expression 
and release of these molecules in SS salivary glands suggests that SGECs possibly act 
as nonprofessional antigen-presenting cells for activating T cells and modulating innate 
and adaptive immune responses leading to the pathogenic features of (SS)
40, 42, 43
. 
1.3 P2X7 nucleotide receptor 
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In addition to its role as a source of energy in intracellular metabolism and 
signaling, ATP is well established as an extracellular signaling molecule that regulates 
various physiological processes, including immune cell recruitment, neurotransmission 
and pain perception
47-50
. Under normal conditions, the levels of extracellular ATP 
(eATP) are tightly regulated by ecto-ATPases
51
, however, in the microenvironment of 
injured, inflamed or stressed cells, eATP is known to be present at high 
concentrations
52
. Extracellular ATP is the natural agonist for most members of the 
purinergic receptor family, which includes the ionotropic P2X (P2X1-7) and the G 
protein-coupled P2Y (P2Y1,2,4,6,11-15) receptors
53
. The P2X7 receptor (P2X7R) is of 
particular interest as its activation is linked to a number of inflammatory diseases, e.g., 
glomerulonephritis, neuroinflammation and rheumatoid arthritis
54-57
. P2X7R is a 595 
amino acid protein that includes 2 transmembrane domains, intracellular carboxy and 
amino termini and a bulky hydrophilic extracellular loop with a cysteine rich region 
that forms disulfide bridges
53, 58
 (Fig. I-1). P2X7R is an ionotropic ligand-gated cation 
channel
53
 and is activated by high eATP concentration (100 M); mainly present at 
sites of cell injury or inflammation
53
. Accordingly, the P2X7R is viewed as a detector 
of high levels of eATP that initiates inflammatory and apoptotic responses
58, 59
. The 
ligand for activation of the P2X7R is extracellular ATP
4-
, not ATP, as the activity of the 
receptor increases when divalent cation concentrations decrease
60
. Brief stimulation of 
the P2X7R with ATP will cause the depolarization of the plasma membrane due to the 
opening of a membrane cation channel that promotes the influx of Na
+ 
and Ca
2+ 
and the 
efflux of K
+
. On the other hand, sustained P2X7R activation by ATP can induce the 
opening of a pore permeable to hydrophilic molecules up to 900 Da
53, 61
.  
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Proteomic analysis showed that the P2X7R forms a multiprotein complex with 11 
proteins, including laminin α3, integrin β2, β-actin, α-actinin, supervillin, matrix 
activated MAGuK (membrane-associated guanylate kinase P55), heat shock proteins 70 
and 90 (Hsp70, Hsp90), heat shock cognate protein 71 (Hsc71), phosphatidylinositol 4-
kinase (PI4K) and receptor protein tyrosine phosphatase-beta (RPTPβ), facilitating the 
interaction between the extracellular matrix and the intracellular actin cytoskeleton and 
signaling cascades
62
. More than 500 single nucleotide polymorphisms are known to 
occur in the P2X7R which are accompanied by an increase or decrease in receptor 
function
63
. There are ten known P2X7R isoforms namely P2X7R-B through K, five of 
which are truncated variants lacking a C-terminus
64, 65
. These isoforms tend to hetero-
oligomerize with the full length P2X7R and hence regulate its function
64, 65
. For 
example, P2X7J binds to the full length P2X7R and negatively regulates the receptor’s 
function by blocking P2X7R-induced apoptosis
66
. Several studies investigated the 
relationship between the expression of the P2X7R variants and the development of 
diseases
67-69
 but there were no definitive conclusions drawn. 
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1.4 P2X7R and inflammation 
The P2X7R is widely expressed in diverse tissues, including hematopoietic 
cells, neurons, glial cells, bone, muscle, endothelial cells and epithelial cells
53
. High 
concentrations of eATP act as a “danger signal”, which activates the P2X7R to initiate 
signaling cascades that produce pro-inflammatory cytokines, e.g., IL-1β, IL-18, IL-6, 
IL-8 and TNF-α, to enable antigen-presenting cells (APCs) to initiate innate immune 
responses
59, 70-74
. IL-1β is a leaderless pro-inflammatory cytokine whose production 
stimulates T cell and macrophage activation, in addition to the expression of cyclic 
Human P2X7 receptor and innate immunity. J. S. Wiley et al. 2011 
Figure I-1 The structure of P2X7R. P2X7R is composed of two transmembrane domains and a bulky extracellular loop. 
Both the amino (N-) and carboxy (C-) termini reside in the cytoplasm. More than 500 single nucleotide polymorphisms 
(SNP’s) are known in P2X7R, some are gain of function (green circles) and some are loss of function (red circles) mutations 
and some have no effect (orange). The blue oval clouds are dileucine motifs required for trafficking and protein sorting from 
the ER to the plasma membrane. The purple boxes are asparagine residues necessary for glycosylation required for proper 
folding in the ER. 
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oxygenase type 2 (COX-2)
59
. The P2X7R plays a key role in the release of IL-1β in 
monocytes, macrophages and microglia
70, 75
. The efficient release of IL-1β requires two 
consecutive stimuli. The first is an inflammatory insult, e.g., lipopolysaccharide 
(LPS)
76
, which acts on toll-like receptors (TLRs) to activate the classical nuclear factor 
κB (NF-κB) cascade and produce the immature 31 kDa pro-IL-1β61, 63. The pro-IL-1β 
accumulates in the cytoplasm whereupon a second stimulus, eATP, activates the 
P2X7R to stimulate the cleavage of immature pro-caspase-1 to active, mature caspase-1 
upon oligomerization of the multiprotein complex NLRP3 type inflammasome
59, 77, 78
. 
Caspase-1 within the inflammasome cleaves immature pro-IL-1β (31 kDa) to mature 
IL-1β (17 kDa), which is released to the extracellular milieu77-80(Figure I-2). 
In addition to IL-1β, the P2X7R is involved in the production of IL-18, i.e., 
interferon-ɣ (IFN-ɣ) -inducing factor, in monocytes74, 81. Immature pro-IL-18 is also 
cleaved by caspase-1 to produce mature IL-18 through inflammasome activation
82
. IL-
18 consequently will modulate the production of other cytokines (e.g., IL-1β, IL-6, 
TNF-α and IFN-ɣ) and chemokines in addition to increasing the expression of adhesion 
molecules such as ICAM-1 and VCAM-1
61, 81
. In mast cells, P2X7R stimulation 
promotes the expression of IL-4, IL-6 and TNF-α71. Fibroblasts were also reported to 
release IL-6 in rheumatoid arthritis and atherosclerosis due to P2X7R activation by 
ATP present in synovial fluid or released from platelets
59, 72
. Moreover, in cultured 
primary mouse microglial cells, treatment with ATP or the high affinity P2X7R agonist 
BzATP caused an increase in the release of IL-6 and the chemokines CCL2 and TNF-α, 
which regulate neurotoxic and neuroprotective responses that are absent in mice devoid 
of the P2X7R (P2X7R
-/-
)
73, 83
. It is noteworthy to mention that the P2X7R is 
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upregulated in microglial cells surrounding β-amyloid plaques in the brains of a 
transgenic Alzheimer’s disease mouse model (i.e., Tg2576), where it is responsible for 
the release of superoxide ions and other pro-inflammatory cytokines that cause 
neurotoxicity
84
. Also, it was reported that the simultaneous treatment with TNF-α and 
IFN-ɣ upregulated P2X7R expression in the THP-1 monocytic cell line85.  
The P2X7R mediates inflammatory responses in various cells, and several 
different diseases, although the majority of P2X7R studies have been done in immune 
cells. The P2X7R is responsible for the generation of lung inflammation associated with 
cigarette smoke in mice, a response that is significantly reduced in P2X7R
-/-
 mice
86
. 
Similarly, in a neuropathic pain mouse model lacking the P2X7R (P2X7R
-/-
), chronic 
inflammation and hypersensitivity to pain resulting from mechanical or thermal stimuli are 
completely absent
87
. Also, the P2X7R is involved in inflammatory responses in epithelial 
cells. In salivary gland epithelial cells (SGECs), stimulation of the P2X7R with ATP or 
BzATP increased caspase-1 activity and immune cell infiltration in wild type but not the 
P2X7R
-/-
 mice 
88
. In intestinal epithelia in inflammatory bowel disease, P2X7R activation 
is accompanied by an increase in caspase-1 activity and IL-1β release in response to ATP 
released by infiltrating polymorphonuclear leukocytes
89
.  
The role of the P2X7R in the development and progression of different cancer 
types is well established. The P2X7R is activated by concentrations of ATP present in the 
inflammatory microenvironment of tumors. In prostate cancer, P2X7R activation results in 
increased invasion and metastasis of cancer cells due to the increased expression of genes 
regulating epithelial mesenchymal transition, including matrix metalloproteinase-3, E-
cadherin and Snail
90
. In pancreatic ductal adenocarcinoma, inhibition of the P2X7R 
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prevents the proliferation of these cancer cells
91
. Importantly, the P2X7R together with 
components of the NLRP3 inflammasome were found to be upregulated in head and neck 
cancer patients
92
. The co-activation of the P2X7R with the NLRP3 inflammasome was 
correlated with invasiveness of the tumor, whereas their inhibition causes cancer cell 
death
92
. Interestingly, several studies demonstrate that the ability of the P2X7R to induce 
apoptosis of cancer cells, making P2X7R activation a potential therapeutic approach for 
the treatment of various cancer types. For example, acute myeloid leukemia and leukemic 
stem cells express high levels of the P2X7R whose activation with ATP results in 
cytotoxicity and apoptosis, a response not seen in normal stem cell populations
93
. The dual 
role of the P2X7R in the regulation of inflammation and apoptosis, particularly in 
cancerous tissues, highlights the difficulties of understanding these complex mechanisms 
in an intact organism, but clearly warrants further investigation. 
1.5 P2X7R and the inflammasome 
The inflammasome is a multiprotein complex and a molecular platform 
responsible for the activation of caspase-1 and caspase-5 with the subsequent maturation 
of pro-inflammatory cytokines, i.e., IL-1β and IL-1878. There are several types of 
inflammasomes, including NLRP3 (also called NALP3), IPAF and AIM2. The NLRP3 
inflammasome is of particular importance in this study because of its role in SS where 
recently, Baldini et al. reported that all of the NLRP3 components and the P2X7R are 
upregulated in salivary gland biopsies from SS patients compared to non-disease 
controls
94
. The NLRP3 inflammasome is composed of NLRP3 protein, ASC protein and 
pro-caspase-1 (Figure I-2). The NLRP3 protein includes a central NACHT domain for 
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oligomerization and nucleotide binding, an amino terminal leucine rich domain (LRR) and 
a carboxy terminal caspase recruiting domain (CARD) or pyrin domain (PYD)
78
 (Figure I-
2). The NLRP3 inflammasome is activated and oligomerizes in response to several host-
derived molecules, e.g.,  amyloid-β peptides of β-amyloid plaques in Alzheimer’s 
disease
95
, monosodium urate crystals (MSU) in gout
96
 and extracellular ATP
97
. The 
mechanism of activation and assembly of the NLRP3 inflammasome by different 
activators is still unclear. It was suggested that some activators, such as bacterial 
peptidoglycans, will directly bind to the LRR domain of the inflammasome triggering its 
assembly. On the other hand, Petrilli et al.
80
 and others reported that K
+
 efflux and reactive 
oxygen species (ROS) are required for inflammasome assembly and activation in mouse 
macrophages and human THP-1 monocytes
80, 98, 99
. Also, in contrast to the key role of 
ROS in activation of the inflammasome, it was found in THP-1 macrophages that 
thioredoxin interacting protein (TXNIP) at high ROS levels is released from oxidized 
thioredoxin (TRX) and binds to the inflammasome leading to its activation
100
. Moreover, 
it was reported that CD4
+
 effector T cells suppress inflammasome  
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activation in bone marrow derived macrophages (BMDMs), depending on cell to cell 
contact through TNF ligands
101
. This is viewed as a way to control innate immunity by 
The Inflammasomes. Kate  Schroder, Jurg  Tschopp. Cell, Volume 140, Issue 6, 2010, 821–832 
Figure I-2. The NLRP3 inflammasome. The release of mature IL-1β requires 2 consecutive stimuli. The first 
stimulus is an inflammatory insult, e.g., LPS that induces the production of pro-IL-1β which accumulates in 
the cytoplasm. The second stimulus, e.g. ATP, upon inflammasome assembly, activates caspase-1 and 
promotes the maturation and release of IL-1β. Three models are shown for inflammasome activation: 1. eATP 
activates the P2X7R which induces K+ efflux and recruitment of the pannexin-1 hemichannel to induce pore 
formation through which NLRP3 agonists enter the cell to activate the inflammasome; 2. crystalline or 
particulate NLRP3 agonists are engulfed by the cells causing the rupture of the lysosome, thereby releasing its 
contents, some of which act as inflammasome agonists and 3. reactive oxygen species (ROS) produced by 
NLRP3 agonists. 
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regulating the production of the leaderless pro-inflammatory cytokines IL-1β and IL-18101. 
Furthermore, Mayor et al.
102
 showed in THP-1 cells that both heat shock protein 90 
(HSP90) and SGT-1 chaperones are essential for NLRP3 inflammasome activity. Also, 
they showed that the absence of HSP90 reduced NLRP3-dependent gout inflammation in 
mice after injection with monosodium urate crystals
102
. 
There are several models proposed for the mechanism of NLRP3 
inflammasome activation (Figure I-2), one of which is through P2X7R activation by 
eATP that induces K
+
 efflux and recruitment of the pannexin-1 hemichannel to form 
pores through which NLRP3 agonists enter the cells
103
. In a second model, crystalline or 
particulate NLRP3 agonists are engulfed by the cells causing rupture of the lysosome, 
which releases its contents, some of which act as inflammasome agonists
95, 104
. A third 
model is through reactive oxygen species (ROS) produced by all NLRP3 agonists, and 
inhibition of ROS production has been shown to suppress inflammasome activity
80, 98
. 
The major sources of ROS are NADPH oxidase (NOX) (a family of seven homologs) 
and the mitochondrial electron transport chain. The contribution of NOX as a source of 
inflammasome-activating ROS is controversial. Some research indicates that knockout 
of the P22
PHOX
 subunit of NOX abolishes IL-1β secretion99, whereas other studies show 
that loss of NOX function or knockout of NOX1, NOX2 and NOX4 did not affect 
inflammasome activity
105, 106
. Furthermore,  a hyperinflammatory response was still seen 
in the lungs of NOX-deficient mice
107
. The mitochondria is another potential source of 
ROS, mainly generated through the electron transport chain at complex I and the Q 
cycle in complex III
108, 109
. Mitochondrial ROS are triggers for the activation of the 
NLRP3 inflammasome in murine and human macrophages upon ATP or nigericin 
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treatment, a response that was abolished in presence of the mitochondrial specific ROS 
scavenger Mito-Tempo
110, 111
. In bronchial epithelial cells, mitochondrial ROS are also 
responsible for airway inflammation in bronchial asthma
112
. The of this study is to 
elucidate the role of the P2X7R in salivary gland inflammation and its dependence on 
the activation and assembly of the NLRP3 inflammasome multiprotein complex.  
1.6 P2X7R and apoptosis 
Apoptosis or programmed cell death is defined as the physiological process 
leading to cell death where cells undergo several morphological changes including cell 
shrinkage and plasma and nuclear membrane blebbing, biological changes such as 
chromatin condensation and nuclear fragmentation and biochemical changes including 
activation of various caspases (cysteine dependent proteases specific for aspartic acid 
residues) and endonucleases
113
. ATP stimulation of cells can cause cell death depending 
on the dose of ATP, the exposure time and the cell type
114
. The P2X7R is responsible for 
the ATP-induced apoptosis in T-cells, where P2X7R-mediated cell death occurs through 
two independent pathways, C-terminal-dependent apoptosis which involves pore 
formation and influx of extracellular chloride ions
115, 116
, and N-terminal-dependent 
necrosis which involves ERK1/2 phosphorylation
116
. Verhoef et al. reported that 
stimulation of the P2X7R with ATP activates Rho A and ROCK-1 which induces 
membrane blebbing (a hallmark of apoptosis) in both HEK-293 and BAC1 macrophage 
cell lines
117
. In the RAW 264.7 macrophage cell line, P2X7R activation stimulates NOX2 
to generate ROS that induce the activation of caspase-3 (a principal regulator of apoptosis) 
through the ASK1-P38-MAPK pathway
118
. Moreover, in Par C5 parotid salivary gland 
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epithelial cells, P2X7R activation causes Ca
2+
-dependent ROCK1 activation and myosin 
light chain (MLC) phosphorylation that leads to membrane blebbing and apoptosis
119
. The 
P2X7R was reported to mediate apoptosis in cervical epithelial cells
120
 and rat primary 
cortical neurons through caspase-8/9/3 activity
121
. On the other hand, the P2X7R in the 
absence of ATP activates phagocytosis of apoptotic cells by mononuclear phagocytes
122
.  
These results suggest that blocking P2X7R activity should prevent apoptosis, thereby 
reducing tissue damage to maintain normal cell functions. 
Interestingly, P2X7R activation can enhance cell growth. Endogenous ATP release 
from cells induces proliferation of neighboring cells by an autocrine/paracrine mechanism. 
In T lymphocytes, P2X7R activation by ATP acts as a costimulator of proliferation in cells 
treated with mitogen-like phytohemagglutinin
123
. The same result was obtained in the K-
562 and LG14 lymphoid cell lines, where P2X7R activation by endogenous ATP release 
maintained proliferation in the absence of serum, a response absent in cells lacking the 
P2X7R and treated with an ecto-ATPase inhibitor
124
. The role of P2X7R in cell death and 
survival is seemingly contradictory, but depends on the level of P2X7R activation. There 
is a dose-dependent relationship between eATP and the cellular response to P2X7R 
activation that is affected by the rate of extracellular ATP hydrolysis and is difficult to 
evaluate in vivo. In general, stimulation of the P2X7R by low levels of eATP induces cell 
proliferation, whereas high eATP concentrations promote cell death. 
1.7 P2X7R and autoimmune diseases 
The P2X7R plays a key role in inflammatory and immune responses in various cell 
types. Hence, the P2X7R has emerged as an interesting therapeutic target for several 
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autoimmune inflammatory diseases. Rheumatoid arthritis (RA) is an autoimmune disease 
characterized by chronic inflammation and deformation of bones and cartilage of 
diarthroidal joints
125
. High levels of purine and pyrimidine nucleotides have been found in 
the synovial fluid of RA patients which stimulates P2X7R-mediated IL-6 release from 
synovial fluid fibroblasts, a key inflammatory event that contributes to the pathology of 
RA
35, 126, 127
. In addition, the P2X7R is responsible for the release of the pro-inflammatory 
cytokines IL-1β and IL-18 that are implicated in chronic joint inflammation seen in RA128. 
Systemic lupus erythematosus (SLE) is another autoimmune disease characterized by 
disturbances in innate and adaptive immune responses that result in the destruction of 
several organs, including lung, kidney, skin and bone marrow
129
. In humans, the P2X7R is 
upregulated in patients with autoimmune disease-related glomerulonephritis
130
. Also, the 
P2X7R and NLRP3 inflammasome components are upregulated in the kidneys of SLE 
rodent models
131
. Activation of the P2X7R in splenocytes and bone marrow cells induces 
the assembly of the inflammasome multiprotein complex and the release of 
proinflammatory cytokines, including IL-1β and IFN-γ, the signature of SLE132.  
Antagonizing the P2X7R in the MLR/lpr SLE mouse model
131
 or the pristane-induced 
lupus nephritis mouse model
132
 significantly reduces levels of circulating autoantibodies, a 
hallmark of SLE, and diminishes lupus nephritis, respectively
131, 132
. In this study, the 
contribution of the P2X7R to the autoimmune inflammatory disease SS was determined 
for the first time and results indicate that P2X7R antagonism is a promising therapeutic 
strategy to limit salivary gland inflammation and associated hypofunction. 
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1.8 P2X7R and clinical studies 
Based on the significant contribution of the P2X7R to inflammatory responses in 
several diseases, particularly autoimmune diseases,
133
 P2X7R antagonists were 
investigated in phase I and phase II clinical trials for the treatment of inflammatory bowel 
syndrome, spinal cord injury and rheumatoid arthritis
35, 134, 135
. P2X7R antagonists have 
shown promising clinical efficacy and proven to be safe in patients
35, 134, 135
. Future studies 
are still required to improve the clinical efficacy of P2X7R antagonists and to further 
investigate the precise role of the P2X7R in each disease context to develop more specific 
P2X7R-based therapies. 
1.9 P2X7R and salivary gland function 
Salivation is a calcium (Ca
2+
) dependent process
136
 and is induced by activation of 
the muscarinic (cholinergic) and α-adrenergic receptors by their ligands acetylcholine and 
nor-epinephrine, respectively. This results in a sustained increase in the intracellular 
calcium concentration [Ca
2+
]i and the generation of primary isotonic saliva by salivary 
acinar cells, which is then modified to its final hypotonic form by salivary ductal cells
136
. 
P2X7R activation by eATP is accompanied by a sustained elevation in intracellular 
calcium levels, which also promotes salivation, a response abolished in P2X7R
-/-
 mice
136, 
137-138, 139
. Nakamoto et al. reported that costimulation of SMG cells with ATP and a 
muscarinic agonist has an inhibitory effect on saliva production
137
, demonstrating that 
P2X7R activation regulates excretory function of the salivary gland
85
. Thus, blocking the 
P2X7R should improve secretory function of the salivary gland, whereas increased 
expression and activation of the P2X7R, particularly during inflammation, should reduce 
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muscarinic receptor-induced salivation. Contrary to Nakamoto’s findings, Novak et al. 
concluded that muscarinic receptors act synergistically with P2X7R to enhance saliva 
secretion
138
. Therefore, the role of P2X7R in regulating the salivary gland excretory 
function needs further investigation. 
1.10 P2Y2 nucleotide receptor 
 The P2Y2 nucleotide receptor (P2Y2R) is a member of the P2 nucleotide receptor 
family and is activated equipotently by eATP and uridine 5’-triphosphate (UTP). The 
P2Y2R is upregulated in the epithelium of inflamed and/or damaged salivary glands
140-144
. 
The role of the P2Y2R is well established in tissue repair; it induces wound healing in 
corneal epithelium by triggering cell migration
145
, liver regeneration by stimulating 
hepatocyte proliferation
146
 and enhances epithelial cell repair in inflammatory bowel 
syndrome
147
. Additional studies have shown that P2Y2Rs regulate localized immune 
responses, induce immune cell infiltration
148
 and upregulate VCAM-1 expression
142
. 
Notably, our previous studies showed that IL-1β increases NF-κB-dependent expression 
of the P2Y2R
147, 149
. Thus, P2X7R and P2Y2R may partner in the initiation of an 
inflammatory response and epithelial tissue repair during inflammation. 
1.11  Mouse models of salivary gland inflammation  
1.11.1 CD28
-/-, IFNγ-/-, NOD.H-2h4, a murine model of salivary gland autoimmune 
exocrinopathy 
The CD28
-/-, IFNγ-/-, NOD.H-2h4 mouse model was developed to study autoimmune 
thyroid disease
150
. The lack of IFN-γ results in increased hyperplasia and proliferation of 
thyroid epithelial cells
151
, whereas the lack of CD28 results in the depletion of Treg 
cells
152
 and extensive immune cell infiltration of the thyroid gland, a hallmark of 
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autoimmune thyroiditis
150
. Interestingly, female CD28
-/-, IFNγ-/-, NOD.H-2h4 mice 
develop hypofunction and immune cell infiltration of the salivary gland by 4 months of 
age, which become more pronounced by 6 months of age, clinical manifestations of SS. 
The male CD28
-/-
, IFNγ-/-, NOD.H-2h4 mice showed fewer and smaller lymphocytic foci 
than female mice at 4 months of age that is unchanged at 6 months, and this diminished 
response compared to female mice is consistent with the 9:1 female to male prevalence of 
SS in humans
153
. The autoantibodies anti-Ro and anti-La that are elevated in human SS 
were undetectable in the CD28
-/-, IFNγ-/-, NOD.H-2h4 mice150. Nonetheless, the CD28-/-, 
IFNγ-/-, NOD.H-2h4 is an excellent mouse model to study the role of the P2X7R in 
salivary gland autoimmune exocrinopathy associated with SS. 
1.11.2 Salivary gland duct ligation/deligation mouse model 
Salivary gland duct ligation and subsequent deligation is a well-studied animal 
model of salivary gland inflammation (ligation) and regeneration (deligation)
144, 154
. In 
this model, the main excretory duct of the submandibular gland (SMG) is surgically 
occluded and after a set period of time (~1-30 days) the process is reversed. Within 24 
hours of duct ligation, immune cells begin to infiltrate the gland and acinar cells begin to 
atrophy, lose expression of acinar proteins and eventually undergo apoptosis
155
. Ductal 
cells, subsets of which have been proposed to be salivary progenitor cells that can 
regenerate the gland, remain intact and proliferative during duct ligation
156-158
. 
Additionally, ligation causes salivary glands to become fibrotic
159
. 
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1.12 Research goals and experimental approaches 
The role of P2X7R activation by eATP in inflammasome assembly and activation 
has been extensively studied in immune cells, but not in salivary gland epithelial cells. 
P2X7R activation by eATP opens a plasma membrane cation channel that mediates the 
downhill influx of Na
+
 and Ca
2+
 and the efflux of K
+53
. P2X7R activation is also 
implicated in the production of ROS through the stimulation of NADPH oxidase 
(NOX2)
118
. Deplano et al. found that macrophages infiltrating WKY rat nephritic 
glomeruli showed higher expression of the P2X7R and enhanced production of caspase-1, 
IL-1β and IL-18 after induction of nephrotoxic nephritis54. They concluded that P2X7R-
mediated inflammasome activation regulates susceptibility to macrophage-dependent 
crescentic glomerulonephritis
54
. In alveolar macrophages, hyperoxia-induced 
inflammasome activation is dependent on P2X7R activation and the accompanying K
+
 
efflux and ROS production
160
. The P2X7R antagonist (oxidizedATP), a high extracellular 
[K
+
] (to inhibit K
+
 efflux) or a ROS inhibitor, prevented hyperoxia-induced inflammasome 
activation
160
. Pelegrin and Surprenant co-immunopreciptated the hemichannel protein 
pannexin-1 with the P2X7R in J-774 macrophages, and determined that pannexin-1 
inhibition with siRNA or mimetic inhibitory peptides abrogated ATP-induced caspase-1 
and IL-1β production and activation but did not affect ATP-, nigericin- or maitotoxin-
induced K
+
 efflux, leading to the conclusion that pannexin-1 acts downstream of K
+
 efflux 
and upstream of caspase-1 cleavage in the regulation of inflammasome activity
161, 162
. In 
contrast, Riteau et al. reported that pannexin-1 is required for the release of endogenous 
intracellular ATP with subsequent P2X7R stimulation by eATP, leading to NLRP3 
inflammasome activation and IL-1β production in macrophages upon internalization of 
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uric acid, silica or alum crystals
163
. Finally, HSP90 which is essential for activation of the 
NLRP3 inflammasome
102
, is a constituent of the P2X7R multiprotein complex
62
 and acts 
as a negative regulator of the assembly and function of P2X7R within the complex
164
. 
HSP90 when bound to the P2X7R (but not in the cytosol) is tyrosine phosphorylated, and 
its phosphorylation level increases when P2X7R function decreases (i.e., when P2X7R-
induced membrane blebbing and ionic currents decrease)
164
. The dependence of 
inflammasome activation on P2X7R stimulation by eATP has been studied in immune 
cells, where it is well established that P2X7R activation plays a crucial role in the 
assembly and activation of the inflammasome. Hence, we hypothesized that P2X7R 
activation by eATP would result in the activation and assembly of the NLRP3 
inflammasome together with the enhanced maturation and release of the pro-inflammatory 
cytokine IL-1β in salivary gland epithelial cells. This hypothesis was addressed using 
primary SMG epithelial cell aggregates isolated from P2X7R and P2X7R
-/-
 C57/B6 mice. 
The mechanism of P2X7R-induced NLRP3 inflammasome activation and IL-1β release 
was determined.  Finally, P2X7R antagonism was examined as a therapeutic approach in 
vivo in the CD28
-/-, IFNγ-/-, NOD.H-2h4 mouse model of autoimmune exocrinopathy150. 
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Chapter II 
P2X7 receptor antagonism prevents IL-1β release from salivary 
epithelial cells and reduces inflammation in a mouse model of 
autoimmune exocrinopathy 
As found in: Khalafalla, M.G., Woods, L.T., Camden, J.M., Khan, A.A., Limesand, 
K.H., Petris, M.J., Erb, L. and Weisman, G.A., 2017. P2X7 receptor antagonism prevents 
IL-1β release from salivary epithelial cells and reduces inflammation in a mouse model 
of autoimmune exocrinopathy. Journal of Biological Chemistry, 292(40), pp.16626-
16637. 
ABSTRACT 
Salivary gland inflammation is a hallmark of Sjögren’s syndrome (SS), a common 
autoimmune disease characterized by lymphocytic infiltration of the salivary gland and 
loss of saliva secretion, predominantly in women. The P2X7 receptor (P2X7R) is an 
ATP-gated non-selective cation channel that induces inflammatory responses in cells and 
tissues, including salivary gland epithelium. In immune cells, P2X7R activation induces 
the production of proinflammatory cytokines, including IL-1β and IL-18, by inducing the 
oligomerization of the multiprotein complex NLRP3-type inflammasome. Here, our 
results show that in primary mouse submandibular gland (SMG) epithelial cells, P2X7R 
activation also induces the assembly of the NLRP3 inflammasome and the maturation 
and release of IL-1β, a response that is absent in SMG cells isolated from mice deficient 
in P2X7Rs (P2X7R
-/-
). P2X7R-mediated IL-1β release in SMG epithelial cells is 
dependent on transmembrane Na
+
 and/or K
+
 flux and the activation of heat shock protein 
90 (HSP90), a protein required for the activation and stabilization of the NLRP3 
inflammasome. Also, using the reactive oxygen species (ROS) scavengers N-acetyl 
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cysteine and Mito-TEMPO, we determined that mitochondrial ROS are required for 
P2X7R-mediated IL-1β release. Lastly, in vivo administration of the P2X7R antagonist 
A438079 in the CD28
-/-, IFNγ-/-, NOD.H-2h4 mouse model of salivary gland 
exocrinopathy ameliorated salivary gland inflammation and enhanced carbachol-induced 
saliva secretion. These findings demonstrate that P2X7R antagonism in vivo represents a 
promising therapeutic strategy to limit salivary gland inflammation and improve 
secretory function. 
2.1 INTRODUCTION 
Salivary gland inflammation and dysfunction are serious clinical problems that 
affect millions of people whose quality of life is severely impacted due to dry mouth, 
periodontitis, oral bacterial and yeast infections and speech problems 
2
. Major causes of 
salivary gland degeneration leading to hyposalivation in humans are the autoimmune 
inflammatory disease Sjögren’s syndrome (SS) and the unintended side effects of 
radiotherapies for head and neck cancers 
2
. A hallmark of salivary gland inflammation in 
SS is mononuclear cell infiltration, mainly T and B lymphocytes, dendritic cells and 
macrophages, which produce proinflammatory cytokines and chemokines and ultimately 
promote salivary gland degeneration in addition to extraglandular manifestations 
including skin vasculitis, glomerulonephritis, peripheral neuropathy and malignant 
lymphomas 
3, 153
. There is increasing evidence that salivary gland epithelial cells 
contribute to immunological responses associated with salivary gland inflammation 
42, 43
, 
hence, understanding the mechanism of initiation of inflammatory events in salivary 
epithelium is crucial to developing more effective and localized treatments for salivary 
gland disorders than are currently available. To date, relatively ineffective therapies for 
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salivary hypofunction include stimulation of salivary flow in residual salivary acinar cells 
of SS patients using  muscarinic receptor agonists (e.g., pilocarpine or cevimeline), oral 
administration of anti-inflammatory agents (e.g., interferon-α) or utilization of artificial 
saliva 
165
.  
In addition to its role as a source of energy in intracellular metabolism and 
signaling, ATP is well established as an extracellular signaling molecule that regulates 
various physiological processes, including immune cell recruitment, neurotransmission 
and pain perception 
47-50
. Under normal conditions, the levels of extracellular ATP 
(eATP) are tightly regulated by ecto-ATPases, however, in the microenvironment of 
injured, inflamed or stressed cells, eATP is known to be present at high concentrations 
52
. 
Extracellular ATP is the natural agonist for most members of the purinergic receptor 
family, which includes the ionotropic P2X (P2X1-7) and the G protein-coupled P2Y 
(P2Y1,2,4,6,11-15) receptors 
53
. The P2X7 receptor (P2X7R) is of particular interest as its 
activation is linked to a number of inflammatory diseases, e.g., glomerulonephritis, 
neuroinflammation and rheumatoid arthritis 
54-57
. P2X7R is widely expressed in 
hematopoietic cells, neurons, glial cells, osteoblasts, endothelial cells and epithelial cells 
53
. Brief stimulation of the ionotropic P2X7R with ATP causes plasma membrane 
depolarization due to Na
+
, Ca
2+ 
and K
+
 flux down their electrochemical gradients 
53, 166
. 
Sustained activation of the P2X7R by high ATP concentrations in some cell types, 
including macrophages, astrocytes and epithelial cells, can lead to the increased 
permeability of hydrophilic molecules up to 900 Da 
167
, membrane blebbing 
88, 168
, 
reactive oxygen species (ROS) production and intracellular nucleotide release resulting in 
cell death 
53
.  P2X7R activation plays a key role in the maturation and release of the 
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leaderless proinflammatory cytokine IL-1β in immune cells by inducing the 
oligomerization of the multiprotein complex NLRP3-type inflammasome 
59, 169
. Notably, 
IL-1β and the components of the NLRP3 inflammasome, including a scaffold NOD-like 
receptor (NLR) protein, NLR family pyrin domain containing protein 3 (NLRP3), 
apoptosis associated speck-like protein containing a CARD (ASC) and pro-caspase-1 
169
, 
along with P2X7Rs, are upregulated in salivary gland biopsies from SS patients, as 
compared to normal controls 
94
. Although widely studied in immune cells, P2X7R-
mediated NLRP3 inflammasome activation in salivary epithelial cells has not been 
investigated. 
P2X7Rs are highly expressed in salivary epithelium 
88, 119
 and have been 
implicated in the regulation of ATP-induced saliva secretion, probably through calcium 
influx 
137
, but their role in salivary gland inflammation is not well understood. Our 
previous studies showed that P2X7R activation by ATP induces inflammatory responses, 
e.g., increases in caspase-1 activity and membrane blebbing, in freshly prepared mouse 
submandibular gland (SMG) cells from wild type mice, but not from P2X7R-deficient 
(P2X7R
-/-
) mice 
88
. In addition, duct-ligation after ATP perfusion in wild type mouse 
SMG increases lymphocytic infiltration, a response that is absent in P2X7R
-/-
 mouse 
SMG 
88
. Studies have shown that P2X7R
-/- 
mice exhibit reduced lung inflammation and 
neuropathic pain as compared to wild type mice 
86, 87
 and systemic administration of 
selective P2X7R antagonists, e.g., A438079, attenuates inflammatory responses in rodent 
models of lung inflammation, nephritis, nociception and intracerebral hemorrhage 
131, 170-
172
. Taken together, the P2X7R represents a novel therapeutic target for reducing 
inflammation 
56, 173
 as further indicated by previous Phase I and II clinical trials with 
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P2X7R antagonists for treatment of rheumatoid arthritis and spinal cord injury 
35, 135
. To 
date, there have been no clinical studies investigating the P2X7R as a therapeutic target 
to prevent salivary gland inflammation. 
Here, we demonstrate for the first time in salivary gland epithelial cells that 
P2X7R activation promotes NLRP3 inflammasome activation and assembly and IL-1β 
release through a mechanism involving transmembrane Na
+
 and K
+
 flux, ROS production 
and HSP90 protein function. Moreover, our in vivo results show that administration of the 
P2X7R antagonist, A438079, in the CD28
-/-, IFNγ-/-, NOD.H-2h4 mouse model of 
autoimmune exocrinopathy 
150
, reduced salivary gland lymphocytic infiltrates and 
enhanced saliva secretion, suggesting that antagonism of the P2X7R is a promising 
approach to prevent salivary gland inflammation and associated hyposalivation in the 
autoimmune disease SS. 
2.2 RESULTS 
2.2.1 P2X7R activation induces the release of IL-1β in primary SMG epithelial cell 
aggregates from wild type, but not P2X7R
-/- 
,
 
mice 
 Activation of the P2X7R in immune cells is well known to play a role in the 
maturation and release of the proinflammatory cytokine, IL-1β 59, 174, 175. We have 
previously shown that P2X7R activation in primary mouse SMG epithelial cell 
aggregates increases the activity of caspase-1, the protease responsible for IL-1β 
processing 
88
, however, it is unclear how P2X7R activation in salivary glands regulates 
IL-1β maturation and release. Here, we show that IL-1β release is significantly increased 
in wild type primary SMG cell aggregates (97-99% epithelial cells, Fig. II-1C) stimulated 
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with ATP (3 mM), as compared to untreated controls (Fig. II-1A).  This response is 
abolished by pretreating aggregates with the P2X7R antagonist A438079 (25 µM), 
whereas IL-1β release induced by the K+ ionophore nigericin (10 µM) is unaffected (Fig. 
II-1A). Moreover, ATP-induced IL-1β release is absent in SMG cell aggregates from 
P2X7R
-/-
 mice (Fig. II-1B). To further validate that SMG epithelial cells are the source of 
IL-1β, rather than immune cells contaminating the SMG cell preparations, epithelial cell 
purity was enriched using the magnetic bead-based EasySep Mouse Epithelial Cell 
Enrichment Kit to remove hematopoietic and endothelial cells and fibroblasts. ATP-
induced IL-1β release was equally robust in the enriched SMG epithelial cells (Fig. II-
1D) and the standard SMG cell preparations (Fig. II-1A), suggesting that SMG epithelial 
cells are the primary source of ATP-induced IL-1β release in our in vitro experiments. 
2.2.2 NLRP3 inflammasome activation is required for P2X7R-mediated IL-1β 
release in primary SMG epithelial cell aggregates 
 Activation of the multiprotein complex NLRP3 inflammasome is responsible for 
the maturation and release of the proinflammatory cytokine IL-1β in a variety of cell 
types including intestinal epithelial cells, monocytes and macrophages 
103, 169, 176
. To 
investigate whether NLRP3 inflammasome activation is required for P2X7R-mediated 
IL-1β release in salivary epithelium, primary SMG cell aggregates from wild type mice 
were pre-treated with the selective NLRP3 inflammasome inhibitors Bay 11-7082 (15 
µM) 
177
 or MCC-950 (10 µM) 
178
 and then stimulated with ATP (3 mM). Results show 
that inhibition of NLRP3 inflammasome activity abolishes ATP-induced IL-1β release 
(Fig. II-2A). Furthermore, immunoprecipitation of NLRP3 was used to demonstrate that 
ATP (3 mM) potentiates co-precipitation of ASC and pro-caspase-1 proteins, components 
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of the NLRP3 inflammasome, in SMG cell aggregates from wild type but not P2X7R
-/-
 
mice (Fig. II-2B). These results indicate that P2X7R-mediated IL-1β release in salivary 
epithelial cells is mediated by activation and assembly of the NLRP3 inflammasome. 
2.2.3 Ionic dependence of P2X7R-mediated IL-1β release in primary SMG epithelial 
cell aggregates 
 P2X7R is an ATP-gated non-selective cation channel whose stimulation induces 
the efflux of K
+
 and influx of Na
+
 and Ca
2+
 ions 
53, 166
.  K
+
 efflux and Na
+
 influx are 
necessary for the activation of the NLRP3 inflammasome complex in immune cells 
80, 179
. 
Therefore, we sought to evaluate the role of transmembrane ion flux in ATP-induced IL-
1β release in salivary epithelial cells. K+ efflux is a necessary response in immune cells to 
various NLRP3 inflammasome activators, including ATP, monosodium urate crystals and 
bacterial lipopolysaccharide 
80, 99, 180
. As mentioned above, the H
+
/K
+
 ionophore nigericin 
induces IL-1β release in primary SMG cell aggregates from wild type and P2X7R-/- mice 
(Fig. II-1), suggesting that K
+
 efflux is required for inflammasome activation in salivary 
epithelium. To determine whether ATP treatment perturbs intracellular K
+ 
homeostasis in 
salivary epithelial cells, primary SMG cell aggregates from wild type and P2X7R
-/-
 mice 
were treated with ATP (3 mM) and the intracellular [K
+
]
 
was quantified with an 
inductively coupled plasma optical emission spectrometer (ICP-OES). ATP induced a 
significant decrease in the intracellular [K
+
]
 
after 10 and 30 min, a response that was 
absent in P2X7R
-/- 
SMG cell aggregates (Fig. II-3A). To determine whether the 
transmembrane [Na
+
] and [K
+
] gradients are required for NLRP3 inflammasome 
activation, primary SMG cell aggregates were assayed for IL-1β release in a buffer 
containing the physiological extracellular [Na
+
] and [K
+
] (145 mM and 5 mM, 
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respectively) or in a buffer where the NaCl (145 mM) was substituted with KCl (145 
mM) or choline chloride (145 mM). Replacement of extracellular NaCl with either KCl 
or choline chloride inhibited ATP-induced IL-1β release (Fig. II-3B), indicating that 
P2X7R-mediated IL-1β release in salivary epithelial cells is dependent on physiological 
transmembrane Na
+
 and K
+
 gradients.  
2.2.4 Inhibition of ROS production significantly reduces P2X7R-mediated IL-1β 
release in primary SMG epithelial cell aggregates 
 ROS are generated by all known inflammasome activators at times of 
inflammation and infection, where they play crucial roles in innate immune responses, 
including wound healing 
181
, and act as anti-microbial agents 
182
. ROS scavengers, e.g., 
N-acetylcysteine (NAC), are known to block inflammasome activity, caspase-1 activation 
and IL-1β release in immune cells 98. To examine whether generation of cytosolic ROS is 
required for ATP-induced IL-1β maturation and subsequent release in salivary epithelial 
cells, primary SMG cell aggregates were pre-treated with the ROS scavenger NAC (25 
mM) and then stimulated with ATP (3 mM). NAC significantly inhibited P2X7R-
mediated IL-1β release (Fig. II-4A). Since the mitochondria is one of the major sources 
of cellular ROS under stress conditions 
111, 183
, the contribution of mitochondrial ROS to 
P2X7R-mediated IL-1β  release was evaluated by pre-treating primary SMG cell 
aggregates with the mitochondrial-targeted anti-oxidant Mito-TEMPO (1 mM), before 
stimulation with ATP (3 mM). Mito-TEMPO partially blocked ATP-induced IL-1β 
release demonstrating that ROS generated in the mitochondria are partially required for 
P2X7R-mediated IL-1β release in mouse SMG epithelial cells (Fig. II-4B) and that other 
sources of ROS (e.g., NADPH oxidase) contribute to inflammasome activation. 
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2.2.5 Functional Heat Shock Protein 90 (HSP90) is required for P2X7R-mediated 
IL-1β release in primary SMG epithelial cell aggregates 
 HSP90 is a molecular chaperone whose function is to maintain the proper folding 
of proteins required for their stability and activity, including proteins of the NLRP3 
inflammasome 
102, 184
. In monocytes, HSP90 is a member of the P2X7R multiprotein 
complex and is required for NLRP3 inflammasome activity 
102
. To determine whether 
HSP90 contributes to P2X7R-mediated IL-1β release in salivary epithelial cells, primary 
SMG cell aggregates were pretreated with the HSP90 inhibitor geldanamycin (GA, 5 
µM), then stimulated with ATP (3 mM). GA abolished ATP-induced IL-1β release in 
salivary epithelial cells (Fig. II-5A), indicating that HSP90 is required for P2X7R-
mediated IL-1β release. Furthermore, GA (5 µM) pre-treatment significantly reduced the 
endogenous expression of NLRP3 protein, suggesting that functional HSP90 contributes 
to inflammasome activity in salivary epithelial cells by maintaining the stability of the 
NLRP3 protein (Fig. II-5B). 
2.2.6 In vivo administration of the P2X7R antagonist A438079 reduces salivary 
gland inflammation and improves saliva flow in the CD28
-/-, IFNγ-/-, NOD.H-2h4 
mouse model of salivary gland exocrinopathy 
 P2X7R antagonists, including A438079, have been shown to reduce 
inflammation in a number of inflammatory diseases including glomerulonephritis, 
pulmonary fibrosis and rheumatoid arthritis 
35, 135
. Hence, we sought to determine if in 
vivo antagonism of the P2X7R in a mouse model of salivary gland exocrinopathy would 
reduce salivary gland inflammation. Recently, we showed that the CD28
-/-, IFNγ-/-, 
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NOD.H-2
h4
 mouse exhibits extensive lymphocytic infiltrates in salivary glands that 
correlate with diminished saliva flow by 4-6 months of age, as compared to the NOD.H-
2
h4
 mouse control 
150
. Therefore, the P2X7R antagonist A438079 (34.2 mg/kg/day) or 
saline was injected intraperitoneally for 10 days in CD28
-/-, IFNγ-/-, NOD.H-2h4 mice. 
Histochemical analysis by hematoxylin and eosin (H & E) staining revealed a decrease in  
lymphocytic infiltrates in SMGs from A438079-injected CD28
-/-, IFNγ-/-, NOD.H-2h4 
mice, as compared to saline-injected control mice (Fig. II-6A). This result was further 
confirmed by RT-PCR analysis where the expression of the pan-immune cell antigen 
CD45 was significantly reduced in response to A438079 treatment (Fig. II-6B), as 
compared to mice injected with saline alone.  
Since ATP-induced inflammasome activation is responsible for the maturation 
and release of the leaderless proinflammatory cytokine IL-1β in mouse SMG cells (Figs. 
II-1 and II-2), we evaluated the role of the P2X7R on the expression of IL-1β in whole 
SMGs isolated from CD28
-/-, IFNγ-/-, NOD.H-2h4 mice injected with the P2X7R 
antagonist A438079 or saline alone. Results indicated that A438079 significantly 
decreased the expression of IL-1β in CD28-/-, IFNγ-/-, NOD.H-2h4 mice, as compared to 
saline alone (Fig. II-7). 
During inflammation, as in SS, salivary gland epithelial cells exhibit aberrant 
expression of immunoactive molecules 
40, 43
 that mediate innate immune responses and 
induce chronic inflammation known as “autoimmune epithelitis” 40.  These immunoactive 
molecules include co-stimulatory molecules (e.g., CD80 and CD86) 
43
 that are required 
for T-cell activation 
185
, and adhesion molecules (e.g., E-selectin, ICAM-1 and VCAM) 
that are required for immune cell homing 
43
. Using RT-PCR analysis, the expression of 
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these molecules was assessed in whole SMGs isolated from CD28
-/-, IFNγ-/-, NOD.H-2h4 
mice following treatment for 10 days with the P2X7R antagonist A438079 or saline 
alone. The results show that expression levels of the adhesion molecules E-selectin, 
ICAM-1 and VCAM (Fig. II-8A) and the co-stimulatory molecules CD80 and CD86 
(Fig. II-8B) were significantly reduced in CD28
-/-, IFNγ-/-, NOD.H-2h4  mice treated with 
A438079, as compared to saline alone.   
Hyposalivation is associated with SS and although its cause is not fully 
understood, inflammation is likely a contributing factor 
186
. Since the CD28
-/-, IFNγ-/-, 
NOD.H-2
h4
 mouse model of autoimmune exocrinopathy exhibits diminished saliva flow 
as compared to the NOD.H-2
h4
 control 
150
, the effects of a 10 day treatment with 
A438079 or saline alone on carbachol-induced saliva flow were compared in CD28
-/-
, 
IFNγ-/-, NOD.H-2h4 mice. Importantly, there was a significant improvement in saliva flow 
in A438079-injected CD28
-/-, IFNγ-/-, NOD.H-2h4 mice (Fig. II-9), as compared to saline-
injected controls.  
2.3 DISCUSSION 
The lack of an understanding of inflammatory processes that predispose the 
salivary gland to degeneration and dysfunction is a major obstacle hindering the 
development of effective therapies to prevent or reverse hyposalivation caused by 
Sjögren’s syndrome (SS) or inadvertent radiation-induced damage from head and neck 
cancer treatments. Epithelial cells have emerged as active players in immune responses 
that underlie inflammation, in addition to their well-accepted role in the formation of a 
physical barrier to the outside environment in a wide variety of tissues.  Inflammatory 
disorders of the epithelium besides SS include inflammatory bowel disease 
187
, primary 
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biliary cirrhosis 
188
, pulmonary fibrosis 
189
 and psoriasis 
190
. In these diseases, changes in 
the morphology and ionic and molecular permeabilities of the plasma membrane of 
epithelial cells initiate interactions with immune cells resulting in tissue inflammation 
42
. 
In SS, salivary epithelial cells participate in inflammatory responses by releasing 
proinflammatory cytokines and chemokines 
42
 and expressing immunoactive molecules 
that modulate early innate immune responses preceding hyposalivation or autoimmune 
exocrinopathy 
40, 43
. While there are multiple reports of inflammatory responses in 
immune cells that are associated with SS, very few studies have focused on salivary 
epithelial cells in the initiation of inflammatory disease despite the critical role played by 
the epithelium in homeostasis required for normal gland functions 
191
. In this study, we 
show that P2X7R activation by eATP in freshly isolated primary mouse SMG epithelial 
cells increases the activity of the multiprotein NLRP3 inflammasome required for the 
subsequent release of the proinflammatory cytokine IL-1β (Figs. II-1 and II-2). These 
data are consistent with reports that the P2X7R stimulates inflammasome activity in 
intestinal epithelial cells 
89
 and immune cells, e.g., monocytes and macrophages 
103, 176
. 
Mechanisms have been proposed in immune cells to define how eATP enhances 
NLRP3 inflammasome activity, including by alteration of the ionic composition of the 
inflammasome’s microenvironment through transmembrane Na+ influx and K+ efflux 80, 
179, 180
. Besides eATP, other activators of the NLRP3 inflammasome in immune cells 
promote K
+
 efflux, including monosodium ureate, peptidoglycan and silica, leading to the 
secretion of mature IL-1β 80, 99, 180. It was reported that in neutrophils following 
Streptococcus pneumoniae infection of the cornea, a low intracellular [K
+
] enhanced 
P2X7R-mediated inflammasome activation and IL-1β maturation and release 174. Also, 
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pro-caspase-1 was not recruited to the inflammasome complex in monocytes in the 
presence of a high extracellular [K
+
] 
80
. However, media devoid of Na
+
 also impaired 
inflammasome activation in human monocytes 
179, 180
. Here, we show that the H
+
/K
+
 
ionophore nigericin induced IL-1β release in SMG cell aggregates prepared from either 
wild type or P2X7R
-/-
 mice (Fig. II-1). Stimulation of the P2X7R with ATP for 10 or 30 
min in wild type salivary epithelial cells resulted in a significant reduction in the 
intracellular [K
+
] that did not occur with SMG cells from P2X7R
-/-
 mice (Fig. II-3A). 
Moreover, P2X7R-mediated IL-1β release was diminished when cells were incubated in a 
high extracellular [K
+
] or in absence of extracellular Na
+
 (Fig. II-3B). These results 
suggest that disruption of the normal transmembrane Na
+
 and K
+
 gradients inhibits 
P2X7R-dependent NLRP3 inflammasome activation and the release of IL-1β.  
In addition to ionic dependence, the generation of ROS is a common response to 
various inflammasome activators, including ATP 
98, 192
, and ROS have been shown to 
enhance inflammasome activity 
80, 98
. Mitochondria are a major source of ROS, hence, 
abnormal mitochondria and uncontrolled ROS production are known to contribute to 
inflammatory diseases, including neurodegenerative diseases and sepsis 
193, 194
. 
Mitochondrial ROS are generated by the electron transport chain in complex I and the Q 
cycle in complex III 
108, 109
. Accumulation of mitochondrial ROS, as a consequence of 
mitochondrial dysfunction, is a trigger for the activation of the NLRP3 inflammasome in 
murine and human macrophages upon ATP or nigericin treatment, a response that was 
abolished in the presence of the mitochondrial-specific ROS scavenger Mito-Tempo 
110, 
111
. In bronchial epithelial cells, mitochondrial ROS induce the co-localization of NLRP3 
and ASC inflammasome proteins in the mitochondria and are responsible for airway 
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inflammation in bronchial asthma 
112
. Consistent with these data, our results show that in 
salivary epithelial cells NAC or Mito-Tempo reduce P2X7R-mediated inflammasome 
activation indicated by a significant decrease in the ATP-induced release of mature IL-1β 
(Figs. II-4A and II-4B). The molecular chaperone HSP90 is also required for NLRP3 
inflammasome stability in monocytes, since it prevents the degradation of the NLRP3 
protein in the absence of inflammation 
102
, a homeostatic mechanism that likely prepares 
cells to respond to inflammasome activators, including ATP. We found that inhibition of 
HSP90 activity in mouse SMG epithelial cells abolishes P2X7R-mediated IL-1β release 
(Fig. II-5A) and significantly reduces the endogenous levels of NLRP3 protein (Fig. II-
5B), consistent with a role for this chaperone in inflammasome stability in salivary 
epithelium.  Taken together, these findings demonstrate for the first time that P2X7R 
activation in salivary gland epithelial cells induces the assembly of an active NLRP3 
inflammasome that regulates the maturation and release of the proinflammatory cytokine 
IL-1β, a pathway that requires physological transmembrane Na+ and K+ gradients, the 
production of mitochondrial ROS and the presence of a functional HSP90 protein. 
P2X7R antagonists have been explored as inhibitors of inflammation in several 
mouse models of inflammatory diseases, including lung inflammation, nephritis, 
nociception and intracerebral hemorrhage 
35, 36, 89, 131, 170-172
, and P2X7R antagonists have 
shown promise in phase I and phase II clinical trials for the treatment of inflammatory 
bowel syndrome, spinal cord injury and rheumatoid arthritis 
35, 134, 135
. In this study, the 
selective P2X7R antagonist A438079 was administered in vivo to CD28
-/-, IFNγ-/-, 
NOD.H-2
h4
 mice that we recently demonstrated develop extensive immune cell infiltrates 
of salivary glands and hyposalivation 
150
. The results revealed that P2X7R antagonism 
dramatically reduced infiltration of CD45-expressing lymphocytes in the SMG of this mouse 
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model of inflammation (Figs. II-6A and II-6B). In addition, A438079 reduced the 
expression of the proinflammatory cytokine IL-1β in SMG (Fig. II-7). The role of IL-1β 
in promoting tissue inflammation and recruiting systemic immune cells is well 
established in several inflammatory diseases, including myocardial infarction, gout and 
rheumatoid arthritis 
195
. Also, IL-1β is known to be upregulated in salivary glands 
isolated from SS patients, as compared to normal controls 
8
.  IL-1β activates the NF-κB 
transcription factor in cells, thereby inducing the expression of several proinflammatory 
genes, including cyclooxygenase-2 and inducible nitric oxide synthase 
196
, which in turn 
increase the production of the proinflammatory factors prostaglandin E2 and nitric oxide 
that are responsible for vasodilation and the recruitment of immune cells to sites of 
inflammation 
196-198
. In addition, IL-1β enhances the expression of cell adhesion 
molecules, including ICAM-1 and VCAM to promote immune cell homing to inflamed 
tissue 
196
. Notably, our previous studies showed that IL-1β increases NF-κB-dependent 
expression of the G protein-coupled P2Y2 receptor (P2Y2R) 
147, 149
, a member of the 
purinergic receptor family. The P2Y2R is upregulated in the epithelium of inflamed 
and/or damaged salivary glands 
140-144
 and upon activation, mediates integrin-dependent 
cell migration and enhances acinar formation 
143
. Additional studies have shown that 
P2Y2Rs regulate localized immune responses, induce immune cell infiltration 
148
 and 
upregulate VCAM-1 expression 
142
. Thus, P2X7R and P2Y2R may partner together in the 
initiation of an inflammatory response and in epithelial tissue repair during inflammation. 
Nonetheless, the reduced expression of IL-1β seen in SMGs of CD28-/-, IFNγ-/-, NOD.H-
2
h4
 mice treated with the P2X7R antagonist A438079 (Fig. II-7) could explain, at least in 
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part, the diminution of lymphocytic infiltrates in the SMGs of this mouse model of 
salivary gland inflammation upon A438079 administration (Figs.  II-6A and II-6B). 
Salivary glands of SS patients exhibit immune cell infiltrates, primarily comprised 
of B- and T-cells 
186
 and increased expression of immunoactive proteins, including the 
co-stimulatory molecules, CD80 and CD86, and the cell adhesion molecules, VCAM, 
ICAM-1 and E-selectin 
43
. The increased expression of immunoactive proteins 
propagates inflammatory responses and enhances the interaction between immune and 
salivary epithelial cells. Here, we show that P2X7R antagonism in CD28
-/-, IFNγ-/-, 
NOD.H-2
h4
 mice induces a dramatic decrease in the expression of the adhesion molecules 
VCAM, ICAM-1 and E-selectin (Figs. II-8A) and the co-stimulatory molecules CD80 
and CD86 (Fig. II-8B), suggesting that P2X7R antagonism could be used to prevent 
chronic inflammation that ultimately results in the loss of salivary gland function 
2
.  
Current treatments for hyposalivation, including muscarinic receptor agonists 
2
, 
do not address the underlying salivary gland inflammation, which is a well-appreciated 
factor in salivary gland dysfunction 
186
, particularly in the autoimmune disease SS. In the 
NOD mouse model of SS, increased expression of proinflammatory cytokines has been 
shown to precede a decrease in saliva flow 
199
. In addition, a recent proteomic analysis of 
saliva from SS patients demonstrated that hyposalivation is associated with increased 
expression and activity of the IL-1 family of proinflammatory cytokines (i.e., IL-1β and 
IL-18) 
186
 and adiponectin, a metabolic regulatory protein that promotes IL-1 cytokine 
interaction with downstream targets 
200
. Some anti-inflammatory drugs such as 
interferon-α, have undergone clinical trials for treatment of salivary gland dysfunction 2. 
Similarly, our results encourage attempts to use P2X7R antagonists to treat 
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hyposalivation in humans, based on the ability of A438079 to enhance the saliva flow 
rate in the CD28
-/-, IFNγ-/-, NOD.H-2h4 mouse model of salivary gland inflammation (Fig. 
II-9).  
In conclusion, we propose a role for the P2X7R in salivary gland inflammation, 
where stimulation of the P2X7R with eATP in salivary epithelial cells induces the 
assembly and activation of the NLRP3 inflammasome and consequently the maturation 
and release of the proinflammatory cytokine IL-1β. This process requires a 
transmembrane Na
+
 and/or K
+
 flux, mitochondrial ROS production and a functional 
HSP90 protein (Fig. II-10). In addition, P2X7R activation is associated with increased 
immune cell infiltration of the salivary gland that eventually results in tissue degeneration 
(Fig. II-10). Hence, this study suggests that P2X7R antagonism represents a novel 
therapeutic strategy to prevent chronic inflammation in human salivary gland 
inflammatory disorders. 
2.4 EXPERIMENTAL PROCEDURES 
2.4.1 Materials 
DMEM/F12 medium and penicillin-streptomycin 100X solution were obtained 
from Life Technologies (Grand Island, NY). All other reagents were purchased from 
Sigma-Aldrich (St. Louis, MO), unless stated otherwise. 
2.4.2 Mice 
Male C57/BL6 (Stock No: 000664) and P2X7R
-/-
 (Stock No: 005576) mice (6-8 
weeks old) were purchased from Jackson Laboratory (Bar Harbor, ME) where the 
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P2X7R
-/-
 mice (stock No: 005576) were originally donated by Pfizer Pharmaceuticals. 
The NOD.H-2
h4
 and CD28
-/-, IFNγ-/-, NOD.H-2h4 mice were provided by Dr. Helen 
Braley-Mullen, Department of Molecular Microbiology and Immunology, University of 
Missouri (Columbia, MO). The mice were bred in the Christopher S. Bond Life Sciences 
Center Animal Facility of the University of Missouri and housed in vented cages with 12 
h light-dark cycles and free access to standard laboratory diet and water. For P2X7R 
antagonism, A438079 (34.2 mg/kg/day) or saline was injected intraperitoneally for 10 
days in CD28
-/-, IFNγ-/-, NOD.H-2h4 mice. The mice were treated under the guidelines 
and approval of the University of Missouri Institutional Animal Care and Use Committee 
(IACUC). 
2.4.3 Preparation of dispersed cell aggregates from mouse SMG 
Dispersed SMG cell aggregates were prepared as previously described 
88
. Briefly, 
mice were anesthetized with isoflurane in a chamber and euthanized by cervical 
dislocation. SMGs were isolated, minced and incubated at 37°C in a shaking water bath 
for 1 h in dispersion media [1:1 DMEM:Ham's F-12 media containing 50 U/ml 
collagenase (Worthington Biochemical, Lakewood, NJ), 400 U/ml hyaluronidase, 1% 
(w/v) BSA and 0.2 mM CaCl2] in an atmosphere of 5% CO2 and 95% O2. For further 
dispersion, the minced SMGs were passed through a 10 ml pipette after 20, 30 and 40 
min of incubation. Finally, the dispersed cell aggregates were filtered through a nylon 
mesh and incubated for an additional hour at 37°C in 1:1 DMEM:Ham's F-12 media 
containing 100 U/ml penicillin and 100 μg/ml streptomycin in an atmosphere of 5% CO2 
and 95% O2, before further use. For further SMG epithelial cell purification, the EasySep 
Role of P2X7R in Salivary Gland Inflammation 
41 
 
Mouse Epithelial Cell Enrichment Kit (Stemcell Technologies, Cambridge, MA) was 
used according to the manufacturer’s protocol.  
2.4.4 IL-1β enzyme linked immunosorbent assay (ELISA) 
Dispersed SMG cells in fresh 1:1 DMEM:Ham's F-12 media containing 100 U/ml 
penicillin and 100 μg/ml streptomycin were incubated with ATP (pH 7.4), nigericin 
(Tocris, Minneapolis, MN), A438079 (Tocris), Bay11-7082 (Tocris), MCC-950 (catalog 
no. AG-CR1-3615, Adipogen, San Diego, CA), geldanamycin (GA) (Tocris, catalog no. 
1368) or the ROS scavengers, N-acetyl cysteine (NAC) or Mito-TEMPO for the 
indicated time periods. Cell supernatants were collected and concentrated using 
Amicon Ultra-0.5 ml centrifugal filter devices. IL-1β was measured in the supernatant 
using the Quantikine IL-1β ELISA kit (R&D Systems, Minneapolis, MN), according to 
the manufacturer’s protocol. To measure the effect of ionic gradient alterations, dispersed 
SMG cells were incubated for 90 min with ATP (3 mM) in a buffer with physiological 
[Na
+
] and [K
+
] (145 mM NaCl, 5 mM KH2PO4, 10 mM HEPES, 1 mM MgCl2, 1 mM 
CaC12 and 1% (w/v) bovine serum albumin (BSA)), pH adjusted to 7.4 with NaOH, a 
buffer with high [K
+
] (145 mM KCl, 5 mM NaH2PO4, 10 mM HEPES, 1 mM MgCl2, 1 
mM CaC12 and 1% (w/v) BSA), pH adjusted to 7.4 with KOH, or a buffer with low [Na
+
] 
in which NaCl is substituted with choline chloride (145 mM choline chloride, 5 mM 
KH2PO4, 10 mM HEPES, 1 mM MgCl2, 1 mM CaC12 and 1% (w/v) BSA), pH adjusted 
to 7.4 with KOH. 
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2.4.5 NLRP3 inflammasome immunoprecipitation 
Dispersed SMG cells from wild type or P2X7R
-/-
 mice were incubated with ATP 
(3 mM) for 15 min. The cells were then collected by centrifugation and incubated in T-
PER lysis buffer (ThermoFisher Scientific, Waltham, MA) with 1X SigmaFast serine, 
cysteine and metalloprotease inhibitors (2 mM AEBSF, 1 mM EDTA, 130 µM bestatin, 
14 µM E-64, 1 µM leupeptin, 0.3 µM aprotinin). NLRP3 in SMG cell lysates (500-1,000 
µg protein/ml) was immunoprecipitated with protein A MagBeads (GenScript, 
Piscataway, NJ) pre-coated with mouse anti-mouse NLRP3 antibody (1:200 dilution; 
Cryo-2, Cat. No. AG-20B-0014-C100, Adipogen, San Diego, CA) by incubation for 1 h 
at room temperature. Immunoprecipitated proteins were solubilized using 40 µl of 1X 
SDS sample buffer (62.5 mM Tris-HCl at pH 6.8, 2% (w/v) SDS, 10% (v/v) glycerol, 50 
mM DL-DTT and 0.01% (w/v) bromophenol blue) followed by heating at 95°C for 5 
min. The samples were then subjected to SDS-PAGE on a 12% (w/v) gel (GenScript, 
Piscataway, NJ) and then transferred to nitrocellulose membranes for Western blot 
analysis.  
2.4.6 Western blot analysis 
Nitrocellulose membranes were blocked for 1 h with 5% (w/v) nonfat dry milk in 
TBS containing 0.1% (v/v) Tween-20 (TBST) and incubated overnight at 4°C with 
mouse anti-mouse NLRP3 antibody (1:1,000 dilution in 5% (w/v) nonfat dry milk in 
TBST, Cryo-2, Cat. No. AG-20B-0014-C100, Adipogen, San Diego, CA), rabbit anti-
mouse ASC antibody (1:1,000 dilution in 5% (w/v) nonfat dry milk in TBST, Catalog no. 
AG-25B-0006, Adipogen, San Diego, CA),rabbit anti-mouse pro-caspase-1 antibody 
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(1:1,000 dilution in 5% (w/v) nonfat dry milk in TBST, Catalog no. ab108362, Abcam, 
Cambridge, MA) or mouse anti-mouse β-tubulin antibody (1:5,000 dilution in 5% (w/v) 
nonfat dry milk in TBST). Membranes were washed three times in TBST and incubated 
with horseradish peroxidase-conjugated goat anti-rabbit IgG or goat anti-mouse IgG 
antibody (1:1,000 dilution in 5% (w/v) nonfat dry milk in TBST, Santa Cruz, Dallas, TX) 
at room temperature for 1 h. Then, blots were washed three times in TBST and incubated 
in enhanced chemiluminescence reagent (ThermoFisher Scientific, Waltham, MA) for 1 
min. Protein bands were detected on X-ray film and quantified using Image Studio Lite 
software (Li-Cor, Lincoln, NE). 
2.4.7 Intracellular [K
+
] quantification 
Dispersed SMG cells from wild type or P2X7R
-/-
 mice were incubated with ATP 
(3 mM) for 0, 10 or 30 min. Cells were then collected by centrifugation and extracted 
with 10% (v/v) ultrapure HNO3. Intracellular [K
+
] was then quantified using an ICP-OES 
(PerkinElmer, Optima 8000) at wavelength 769.9 nm using manganese as the internal 
standard. 
2.4.8 Immunohistochemistry 
Whole SMGs were isolated from CD28
-/-, IFNγ-/-, NOD.H-2h4 mice, placed in 4% 
(v/v) paraformaldehyde in PBS at 4°C for 24 h, followed by 70% (v/v) ethanol for 24 h at 
4°C. Samples were then sent to IDEXX RADIL (Columbia, MO) where glands were 
embedded in paraffin, cut into 5 µm sections and subjected to hematoxylin and eosin 
staining. 
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2.4.9 RT-PCR 
Whole SMGs were excised, homogenized in TRIzol reagent (Life Technologies, 
Grand Island, NY) and incubated for 5 min at room temperature, followed by incubation 
with chloroform (0.2 ml/ml TRIzol) for 5 min at room temperature. Following 
centrifugation at 12,000 g for 15 min at 4°C, the resulting aqueous phase containing RNA 
was collected and DNA-free RNA was isolated using the RNeasy Plus Mini kit (Qiagen, 
Valencia, CA). cDNA was prepared from purified RNA using RNA to cDNA EcoDry 
Premix (Clontech Laboratories, Mountain View, CA). TaqMan probes for CD45 (also 
known as protein tyrosine phosphatase receptor type C, a pan-immune cell marker), IL-
1β, CD80, CD86, ICAM-1, VCAM and E-selectin were obtained from Applied 
Biosystems (Foster City, CA) and used for RT-PCR with an Applied Biosystems 7500 
real-time PCR machine. The mRNA expression of target genes was normalized to 18S 
ribosomal RNA as an internal control and data were analyzed using Applied Biosystems 
software. 
2.4.10 Saliva collection 
Mice were anesthetized with tribromoethanol (Avertin; 0.75 mg/g mouse weight) 
and an endotracheal tube (PE50 polyethylene tubing) was inserted through a 2 cm 
midventral incision to prevent aspiration. Saliva secretion was induced by intraperitoneal 
injection of 0.25 mg/kg carbachol. Saliva was collected from the oral cavity for 15 min 
using a pipette tip and placed in a pre-weighed Eppendorf tube. Results are presented as 
microliters of saliva produced per 15 min. 
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2.4.11 Statistical analysis 
The statistical analyses were performed using Student’s t-test on Graphpad Prism 
software where significant differences were considered to be P < 0.05 
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FIGURES 
Figure  II-1. P2X7R activation induces the release of IL-1β in primary mouse SMG 
cell aggregates. (A) Dispersed SMG cell aggregates from wild type mice were cultured 
in the presence or absence of A438079 (25 µM) for 30 min and then incubated with ATP 
(3 mM) or nigericin (10 µM) for 90 min (n = 4). (B) Dispersed SMG cell aggregates 
isolated from P2X7R
−/−
 mice were incubated with ATP (3 mM) or nigericin (10 µM) for 
90 min (n = 3). Cells were collected by centrifugation and IL-1β was quantified in the 
supernatant using the IL-1β Quantikine ELISA kit. Data represent means ± S.E., where 
**P < 0.01 indicates a significant increase over basal levels, whereas 
##
P < 0.01 indicates 
a significant decrease compared to ATP-treated cells. (C) Wild type dispersed SMG cell 
aggregates were suspended in PBS buffer and non-specific antibody binding was blocked by 
incubation for 10 min at 4 °C with anti-mouse CD16/32 antibody (1µg/ 10
6
 cells in 100 µl, 
Mouse FC block, Cat. No. 553142, BD Biosciences, San Jose, CA). SMG cells were incubated for 
20 min at 4 °C with Alexa Fluor 594-conjugated anti-mouse CD45 antibody (1:50 dilution, clone 
30-F11, Biolegend, San Diego, CA) and then washed 3 times in PBS buffer. Stained cells were 
placed on a 8-well coverslip and fluorescence was visualized using a Nikon TI-E inverted 
microscope equipped with appropriate filters. Images from 3 independent SMG preparations were 
analyzed for immune cell contamination by counting the number of CD45
+
 cells and total number 
of cells. Epithelial cell purity of SMG cell preparations was 97-99%. (D) SMG epithelial cells 
were enriched using the magnetic bead-based EasySep Mouse Epithelial Cell Enrichment Kit to 
remove hematopoietic, endothelial and fibroblast cells. The isolated epithelial cells were 
stimulated with ATP (3 mM) for 90 min and then cells were collected by centrifugation and IL-
1β was quantified in the supernatant using the IL-1β Quantikine ELISA kit. Data represent means 
± S.E., where *P < 0.05 indicate a significant increase over basal levels. 
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Figure II-2. The NLRP3 inflammasome mediates P2X7R-induced IL-1β release. (A) 
Dispersed SMG cell aggregates from wild type mice were cultured in the presence or 
absence of Bay 11-7082 (15 µM) for 1 h or MCC-950 (10 µM) for 30 min and then 
stimulated with ATP (3 mM) for 90 min (n = 3). Cells were collected by centrifugation 
and IL-1β was quantified in the supernatant using the IL-1β Quantikine ELISA kit. Data 
represent means ± S.E., where **P < 0.01 and ***P < 0.001 indicate significant 
decreases from ATP-treated only. (B) Upper panel— Cell lysates from dispersed wild 
type or P2X7R
−/−
 SMG cell aggregates treated with or without ATP (3 mM) for 15 min, 
were subjected to immunoprecipitation (IP) with anti-NLRP3 antibody, followed by 
immunoblotting (IB) with anti-NLRP3, anti-ASC or anti-pro-caspase-1 antibodies. 
Images represent results from 3 independent experiments. Lower panel— Quantification 
of the co-immunoprecipitated proteins in wild type SMG cells (n = 3). Data represent 
means ± S.E., where *P < 0.05 and **P < 0.01 indicate significant increases in relative 
band intensities as compared to basal conditions. 
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Figure II-3 Na
+
 and/or K
+
 efflux is required for P2X7R induced IL-1β release. (A) 
Dispersed SMG cell aggregates from wild type and P2X7R
-/-
 mice were stimulated with ATP (3 
mM) for 0, 10 or 30 min. Then, the intracellular [K
+
] was quantified using ICP-OES and 
expressed as a percentage of the intracellular [K
+
] at 0 min of ATP treatment (n = 3). Data 
represent means ± S.E. where *P < 0.05 indicates a significant decrease from ATP-treated cells at 
0 min. (B) Dispersed SMG cell aggregates from wild type mice were stimulated with ATP (3 
mM) for 90 min in the presence of the specified concentrations of NaCl, KCl or choline chloride 
(n = 4). Cells were collected by centrifugation and IL-1β was quantified in the supernatant using 
the IL-1β Quantikine ELISA kit. Data represent means ± S.E., where **P < 0.01 and ***P < 
0.001 indicate significant decreases from ATP-treated cells in 145 mM Na
+
. 
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Figure II-4 Mitochondrial ROS contribute to P2X7R-induced IL-1β release 
Dispersed SMG cell aggregates from wild-type mice were treated at pH 7 with 3 mM 
ATP for 90 min at 37°C with or without pretreatment with the ROS inhibitor (a) NAC 
(25 mM) or (b) mitochondrial ROS inhibitor Mito-Tempo (1mM) for 1 h. Cells were 
collected by centrifugation and IL-1β release was quantified in the supernatant using the 
IL-1β Quantikine ELISA kit. Data with ATP, NAC/Mito-Tempo-treated wild-type SMG 
cells represent means ± SE (n = 3). *P < 0.05, significant decrease from ATP-treated 
only. 
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Figure II-5 HSP 90 is crucial for P2X7R-induced IL-1β release (A) Dispersed SMG 
cell aggregates from wild-type C57BL/6 mice were treated at pH 7 with 3 mM ATP for 
90 min at 37°C with or without pretreatment with the HSP90 inhibitor geldanamycin 
(GA, 5 µM), for 1 h. Cells were collected by centrifugation and IL-1β release was 
quantified in the supernatant using the IL-1β Quantikine ELISA kit. Data with ATP, GA-
treated SMG cells represent means ± SE (n = 3). **P < 0.01, significant decrease from 
ATP-treated only. (B) Upper panel— Cell lysates from dispersed wild type SMG cell 
aggregates were treated with or without GA (5 µM) for 1 h and subjected to 
immunoblotting (IB) with anti-NLRP3 or anti-β-tubulin antibodies. Images represent 
results from 3 independent experiments. Lower panel— Quantification of NLRP3 
expression in wild type SMG cells (n = 3). Data represent means ± S.E., where *P < 0.05 
indicates a significant decrease in relative band intensity as compared to basal conditions. 
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Figure II-6. P2X7R antagonism ameliorates salivary gland inflammation in CD28
-/-
,
 
IFNγ-/-, NOD.H-2h4 mice. (A) H & E staining of SMG sections isolated from NOD.H-2h4 
or CD28
-/-
,
 
IFNγ-/-, NOD.H-2h4 mice (5 months old) injected intraperitoneally with saline 
alone or the P2X7R antagonist A438079 (34.2 mg/kg/day) for 10 days. Images are 
representative of n =10 mice per each group. (B) cDNA was prepared from SMGs of 
NOD.H-2
h4
 and CD28
-/-
,
 
IFNγ-/-, NOD.H-2h4 mice injected with saline alone or A438079, 
as above, then analyzed by RT-PCR using specific primers for the pan-immune cell 
marker CD45 (n = 5 for NOD.H-2
h4
 mice, n = 9 for saline-injected and n = 10 for 
A438079-injected CD28
-/-
,
 
IFNγ-/-, NOD.H-2h4 mice). Data represent means ± S.E., 
where *P < 0.05 indicates a significant difference from saline-injected CD28
-/-
,
 
IFNγ-/-, 
NOD.H-2
h4
 mice. 
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Figure II-7. P2X7R antagonism reduces IL-1B expression in CD28
-/-
,
 
IFNγ-/-, 
NOD.H-2
h4
 mice. cDNA was prepared from SMGs of NOD.H-2
h4
 and CD28
-/-
, IFNγ-/-, 
NOD.H-2
h4
 mice (5 months old) injected with saline alone or the P2X7R antagonist 
A438079 (34.2 mg/kg/day) for 10 days, then analyzed by RT-PCR using specific primers 
for IL-1B (n = 4 for NOD.H-2
h4
 mice, n = 9 for saline-injected and n = 10 for A438079-
injected CD28
-/-
,
 
IFNγ-/-, NOD.H-2h4 mice). Data represent means ± S.E., where *P < 
0.05 indicates a significant difference from saline-injected CD28
-/-
,
 
IFNγ-/-, NOD.H-2h4 
mice. 
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Figure II-8. P2X7R antagonism reduces expression of immunoactive molecules in 
CD28
-/-
,
 
IFNγ-/-, NOD.H-2h4 mice. cDNA was prepared from SMGs of NOD.H-2h4 and 
CD28
-/-
,
 
IFNγ-/-, NOD.H-2h4 mice (5 months old) injected with saline alone or the P2X7R 
antagonist A438079 (34.2 mg/kg/day) for 10 days, then analyzed by RT-PCR using 
specific primers for (A) ICAM-1, VCAM or E-Selectin or (B) CD80 or CD86 (n = 4 for 
NOD.H-2
h4
 mice, n = 9 for saline-injected and n = 10 for A438079-injected CD28
-/-
, 
IFNγ-/-, NOD.H-2h4 mice). Data represent means ± S.E., where *P < 0.05 and **P < 0.01 
indicate significant differences from saline-injected CD28
-/-
, IFNγ-/-, NOD.H-2h4 mice. 
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Figure II-9. P2X7R antagonism improves saliva flow rate in CD28
-/-
,
 
IFNγ-/-, 
NOD.H-2
h4
 mice. Carbachol-induced saliva flow rate in CD28
-/-
,
 
IFNγ-/-, NOD.H-2h4 
mice
 
(5 months old) injected with saline alone or the P2X7R antagonist A438079 (34.2 
mg/kg/day) for 10 days (n = 9 for saline-injected and n = 10 for A438079-injected CD28
-
/-
,
 
IFNγ-/-, NOD.H-2h4 mice). Data represent means ± S.E., where **P < 0.01 indicates a 
significant difference from saline-injected CD28
-/-
,
 
IFNγ-/-, NOD.H-2h4 mice. 
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Figure II-10. Schematic diagram illustrating the proposed role of the P2X7R in 
salivary gland inflammation. In salivary epithelial cells, P2X7R activation by eATP 
induces the assembly and activation of the NLRP3 inflammasome and the subsequent 
release of mature IL-1β. This process involves efflux of K+ ions, production of ROS and 
the presence of an active HSP90 protein. P2X7R antagonism reduces immune cell 
infiltration and salivary gland expression of IL-1β, ICAM-1, VCAM, E-Selectin, CD80 
and CD86 and enhances carbachol-induced saliva secretion in the CD28
-/-
, IFN-γ-/-, 
NOD.H-2
h4
 mouse model of salivary gland inflammation. 
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Chapter III 
Alternative therapeutic approaches for 
salivary gland inflammation and fibrosis 
3.1 P2Y2 nucleotide receptor activation enhances the aggregation and self-
organization of dispersed salivary epithelial cells 
Hyposalivation resulting from salivary gland dysfunction leads to poor oral 
health and greatly reduces the quality of life of patients
2
. Current treatments for 
hyposalivation are limited
2
. Regenerative medicine represents a revolutionary 
approach to replace dysfunctional salivary glands. Over the past decade, progress has 
been made in cell-based reconstitution strategies for salivary glands. The ability of 
dispersed salivary epithelial cells or salivary gland-derived progenitor cells to self-
organize into acinar-like spheres or branching structures that mimic the native tissue 
holds promise for cell-based reconstitution of a functional salivary gland
201
. However, 
the mechanisms involved in salivary epithelial cell aggregation and tissue 
reconstitution are not fully understood. This study investigated the role of the P2Y2 
nucleotide receptor (P2Y2R), a G protein-coupled receptor that is upregulated 
following salivary gland damage and disease
140, 141
, in salivary gland reconstitution. 
In vitro results with the rat parotid acinar Par-C10 cell line indicate that P2Y2R 
activation with the selective agonist UTP enhances the self-organization of dispersed 
salivary epithelial cells into acinar-like spheres. Other results indicate that the P2Y2R-
mediated response is dependent on epidermal growth factor receptor activation via 
the metalloproteases ADAM10/ADAM17 or the α5β1 integrin/Cdc42 signaling 
pathway, which leads to activation of the MAPKs JNK and ERK1/2. Ex vivo data 
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using primary submandibular gland cells from wild-type and P2Y2R
−/−
 mice 
confirmed that UTP-induced migratory responses required for acinar cell self-
organization are mediated by the P2Y2R. Overall, this study suggests that the P2Y2R 
is a promising target for salivary gland reconstitution and identifies the involvement 
of two novel components of the P2Y2R signaling cascade in salivary epithelial cells, 
the α5β1 integrin and the Rho GTPase Cdc42 (see Appendix 1). 
3.2 Increased expression of TGF-β signaling components in a mouse model of 
fibrosis induced by submandibular gland duct ligation 
One of the consequences of the chronic inflammatory disease SS is the 
fibrosis of the salivary gland and its subsequent hypofunctioning
202
. Transforming 
growth factor-β (TGF-β) is a multi-functional cytokine with a well-described role in 
the regulation of tissue fibrosis and regeneration in the liver, kidney and lung
203-205
. 
Submandibular gland (SMG) duct ligation and subsequent deligation in rodents is a 
classical model for studying salivary gland damage and regeneration
88, 144
. While 
previous studies suggest that TGF-β may contribute to salivary gland fibrosis, the 
expression of TGF-β signaling components has not been investigated in relation to 
mouse SMG duct ligation-induced fibrosis and regeneration following ductal 
deligation. Following a 7-day SMG duct ligation, TGF-β1 and TGF-β3 were 
significantly upregulated in the SMG, as were TGF-β receptor 1 and downstream 
Smad family transcription factors in salivary acinar cells, but not in ductal cells. In 
acinar cells, duct ligation also led to upregulation of Snail, a Smad-activated E-
cadherin repressor and regulator of epithelial-mesenchymal transition, whereas in 
ductal cells upregulation of E-cadherin was observed while Snail expression was 
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unchanged. Upregulation of these TGF-β signaling components correlated with 
upregulation of fibrosis markers collagen 1 and fibronectin, responses that were 
inhibited by administration of the TGF-β receptor 1 inhibitors SB431542 or 
GW788388. After SMG regeneration following a 28-day duct deligation, TGF-β 
signaling components and epithelial-mesenchymal transition markers returned to 
levels similar to non-ligated controls. The results from this study indicate that 
increased TGF-β signaling contributes to duct ligation-induced changes in salivary 
epithelium that correlate with glandular fibrosis. Furthermore, the reversibility of 
enhanced TGF-β signaling in acinar cells of duct-ligated mouse SMG after deligation 
indicates that this is an ideal model for studying TGF-β signaling mechanisms in 
salivary epithelium as well as mechanisms of fibrosis initiation and resolution (see 
Appendix 2). 
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Chapter IV 
Summary and future directions 
4.1 Summary 
Salivary gland inflammation and the associated hyposalivation is a serious 
clinical problem that greatly affects the quality of life of patients resulting in several 
health problems, including oral speech difficulties, oral bacterial infections and digestion 
deficits. The major causes of salivary gland inflammation include the autoimmune 
inflammatory disease SS and radiotherapy for head and neck cancer patients that causes 
salivary gland degradation as a secondary unintended side effect. The current treatments 
for hyposalivation are symptomatic and relatively ineffective, including stimulation of 
salivary flow in residual salivary acinar cells of SS patients using muscarinic receptor 
agonists (e.g., pilocarpine or cevimeline), oral administration of anti-inflammatory agents 
(e.g., interferon-α) or utilization of artificial saliva. The P2X7R is a purinergic receptor 
whose natural agonist is extracellular ATP. The P2X7R is of particular interest as its 
activation is linked to a number of inflammatory diseases, e.g., glomerulonephritis, 
neuroinflammation and rheumatoid arthritis
54-57
. In this study, we investigated the 
contribution of the P2X7R to salivary gland inflammation and examined the possibility 
that P2X7R antagonists can reduce inflammation and restore salivary gland excretory 
function in a mouse model of autoimmune exocrinopathy. 
In summary, the results of this study include the following novel findings: 
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1- The P2X7R contributes to salivary gland inflammation where its stimulation 
promotes NLRP3 inflammasome assembly and activation leading to IL-1β release 
through a mechanism involving downhill transmembrane Na
+
 and K
+
 fluxes, ROS 
production and HSP90 protein function. 
2- In vivo administration of the P2X7R antagonist A438079 in the CD28-/-, IFNγ-/-, 
NOD.H-2
h4
 mouse model of autoimmune exocrinopathy reduced salivary gland 
lymphocytic infiltration, a hallmark of SS. 
3- In vivo administration of the P2X7R antagonist A438079 in the CD28-/-, IFNγ-/-, 
NOD.H-2
h4
 mouse model of autoimmune exocrinopathy reduced the expression 
of the pro-inflammatory cytokine IL-1β which explains, at least in part, the 
diminution of lymphocytic infiltrates in the SMGs of this mouse model of salivary 
gland inflammation. 
4- In vivo administration of the P2X7R antagonist A438079 in the CD28-/-, IFNγ-/-, 
NOD.H-2
h4
 mouse model of autoimmune exocrinopathy reduced the expression 
of immunoactive proteins, e.g., CD80, CD86, ICAM, VCAM and E-selectin, that 
are responsible for the propagation of inflammatory and immune responses seen 
in SS. This result suggests that P2X7R antagonism can be utilized to limit innate 
immune responses, reduce the interaction between immune and salivary epithelial 
cells and prevent chronic inflammation that ultimately results in the loss of 
salivary gland function. 
5- Amelioration of salivary gland inflammation by P2X7R antagonism in the CD28-
/-, IFNγ-/-, NOD.H-2h4 mouse model was associated with a significant 
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improvement in saliva flow, which demonstrates the clinical utility of this 
approach.  
In conclusion, this study suggests that P2X7R antagonism represents a novel 
therapeutic strategy to prevent chronic inflammation and improve hyposalivation in 
human salivary gland inflammatory disorders, including the autoimmune disease SS. 
In other studies, it was shown that P2Y2R activation with the selective agonist 
UTP enhances the self-organization of dispersed salivary epithelial cells into acinar-
like spheres. The P2Y2R-mediated response is dependent on epidermal growth factor 
receptor activation via the metalloproteases ADAM10/ADAM17 or the α5β1 
integrin/Cdc42 signaling pathway, which leads to activation of the MAPKs, JNK and 
ERK1/2. These findings introduce P2Y2R-targeted regenerative medicine as an 
alternative therapeutic approach for replacement of damaged salivary gland tissue 
caused by autoimmune disease or radiation therapy used to treat head and neck 
cancers, by inducing the proliferation, migration and differentiation of residual cells 
in the damaged salivary glands to promote tissue regeneration. 
Finally, TGF-β signaling components were shown to be upregulated after 7 days 
of SMG duct ligation, which correlated with upregulation of the fibrosis markers 
collagen 1 and fibronectin, responses that were inhibited by administration of the 
TGF-β receptor 1 inhibitors SB431542 or GW788388. These data suggest that TGF-β 
signaling contributes to duct ligation-induced changes in salivary epithelium that 
correlate with glandular fibrosis. 
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4.2 Future directions 
The research project presented in this dissertation could be further extended by 
pursuing the following tracks outlined below. 
4.2.1 Investigating the role of the P2X7R in salivary gland epithelial cells 
(SGECs) as nonprofessional antigen-presenting cells. 
The hallmark of SS is the infiltration of T and B cells into salivary glands, which 
is accompanied by the release of pro-inflammatory cytokines, including IL-1β, IL-18, 
IL-6, IL-12, IL-22, TNF-α and IFN-γ, creating an inflammatory environment that 
surrounds the salivary gland epithelium
3, 7, 8
. These inflammatory conditions have 
been suggested to activate the SGECs to modulate the innate and adaptive immune 
responses responsible for the pathogenic features of SS
40, 43
. Activated SGECs 
isolated from SS patients were reported to express constitutively immunoactive 
molecules, e.g., major histocompatibility complex (MHC I and II), costimulatory 
molecules and B cell activating factor (BAFF), in addition to the release of pro-
inflammatory cytokines and chemokines in levels higher than the non-disease 
controls
7, 40, 43
. These molecules were also upregulated in normal SGECs treated with 
IFN-ɣ and TNF-α43. This suggests that SGECs play a role as a nonprofessional 
antigen-presenting cell that activates T cells and modulates the pathogenic features of 
SS
40, 43
. P2X7R activation is involved in the production of TNF-α and IL-18 (IFN-ɣ 
inducing factor) in addition to pro-inflammatory cytokines, e.g., IL-1β, IL-6 and 
others
59, 61, 70-74, 206
, which are responsible for the inflammatory conditions seen in SS
3, 
7, 8
. Also, P2X7R activation induces the release of MHC II in a process-dependent 
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manner upon inflammasome activation
207
. Hence, it would be interesting to determine 
the role of the P2X7R in activating salivary epithelial cells to act as nonprofessional 
antigen-presenting cells. This study would determine whether P2X7R activation 
contributes to the expression of immunoactive proteins in salivary epithelium that 
mediate SGEC interactions with immune cells. Also, this study would investigate the 
ability of SGECs to take-up and present antigens in response to P2X7R activation. 
Primary SMG cells isolated from WT and P2X7R
-/- 
mice will be incubated with 
labelled soluble protein ovalbumin (OVA) antigen (OVA-FITC) at 37°C, with or 
without eATP or BzATP activation (30-180 min). Fluorescence would be monitored 
by fluorescence microscopy. Then to examine the antigen presentation by SGEC, 
immunofluorescence double staining technique could be used. Primary SMG cells 
would be incubated with either the labelled antigen OVA257-264-FITC (SIINFEKL) 
(complexes with MHC I) or OVA323-339-FITC (complexes with MHC II), with or 
without ATP or BzATP stimulation and fluorescence would be monitored using 
fluorescence microscopy. Also, it would be determined whether this response results 
in T cell activation and proliferation. This study would elucidate the role of the 
P2X7R in activating the salivary gland epithelial cells to act as nonprofessional 
antigen-presenting cells for T cells, thereby modulating innate and adaptive immune 
responses underlying the pathogenic features of SS. 
4.2.2 Investigating the genetics of P2X7R in SS 
Several single nucleotide polymorphisms (SNPs) are known in P2X7R that are 
associated with an increase or decrease in receptor function
63
. The P2X7R SNPs 
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mediate susceptibility to a variety of diseases, including tuberculosis
68
. Also, the 
gain of function mutation P2X7R A1405G has been correlated with the 
development of SS in seropositive patients who do not carry the HLA-DR3 risk 
allele
69
, the primary genetic risk factor in SS patients
208
. There are ten known 
P2X7R isoforms, namely P2X7R (B through K), five of which are truncated 
variants lacking the C-terminus
64, 65
. These isoforms tend to hetero-oligomerize 
with the full length P2X7R and hence regulate its function
64, 65
. For example, 
P2X7J binds to full length P2X7R and negatively regulates P2X7R-induced 
apoptosis
66
. Future studies would investigate the relationship between the P2X7R 
SNPs and the expression of P2X7R variants and the development of SS. A better 
understanding of the genetics and physiology of the P2X7R and how this 
correlates with the pathogenesis of SS is necessary to improve P2X7R-targeted 
therapies. 
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Appendix I 
P2Y2 nucleotide receptor activation enhances the aggregation and self-organization 
of dispersed salivary epithelial cells 
As found in: El-Sayed, F.G., Camden, J.M., Woods, L.T., Khalafalla, M.G., Petris, M.J., 
Erb, L. and Weisman, G.A., 2014. P2Y 2 nucleotide receptor activation enhances the 
aggregation and self-organization of dispersed salivary epithelial cells. American Journal 
of Physiology-Cell Physiology, 307(1), pp.C83-C96. 
Abstract 
Hyposalivation resulting from salivary gland dysfunction leads to poor oral health and 
greatly reduces the quality of life of patients. Current treatments for hyposalivation are 
limited. However, regenerative medicine to replace dysfunctional salivary glands 
represents a revolutionary approach. The ability of dispersed salivary epithelial cells or 
salivary gland-derived progenitor cells to self-organize into acinar-like spheres or 
branching structures that mimic the native tissue holds promise for cell-based 
reconstitution of a functional salivary gland. However, the mechanisms involved in 
salivary epithelial cell aggregation and tissue reconstitution are not fully understood. This 
study investigated the role of the P2Y2 nucleotide receptor (P2Y2R), a G protein-coupled 
receptor that is upregulated following salivary gland damage and disease, in salivary 
gland reconstitution. In vitro results with the rat parotid acinar Par-C10 cell line indicate 
that P2Y2R activation with the selective agonist UTP enhances the self-organization of 
dispersed salivary epithelial cells into acinar-like spheres. Other results indicate that the 
P2Y2R-mediated response is dependent on epidermal growth factor receptor activation 
via the metalloproteases ADAM10/ADAM17 or the α5β1 integrin/Cdc42 signaling 
pathway, which leads to activation of the MAPKs JNK and ERK1/2. Ex vivo data using 
primary submandibular gland cells from wild-type and P2Y2R
−/−
 mice confirmed that 
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UTP-induced migratory responses required for acinar cell self-organization are mediated 
by the P2Y2R. Overall, this study suggests that the P2Y2R is a promising target for 
salivary gland reconstitution and identifies the involvement of two novel components of 
the P2Y2R signaling cascade in salivary epithelial cells, the α5β1 integrin and the Rho 
GTPase Cdc42. 
Keywords: salivary gland reconstitution, P2Y2 nucleotide receptor, EGF receptor, α5β1 
integrin, Cdc42 Rho GTPase, extracellular ATP 
Introduction 
Salivary glands are exocrine glands composed of multiple secretory end pieces called 
acini, which secrete saliva into the oral cavity via a system of branched ductal cells, 
including intercalated ducts, striated ducts, and a main excretory duct (52). Saliva 
performs many protective and physiological functions by providing the oral cavity with 
water and electrolytes along with essential proteins, including lubricants, antibacterial, 
antifungal, antiviral, and remineralization agents, digestive enzymes, and growth factors 
(25, 31, 52). Accordingly, hyposalivation due to salivary gland dysfunction resulting 
from the autoimmune disease Sjögren's syndrome (SS) or irradiation therapy for head and 
neck cancers leads to a significant deterioration of oral health and seriously decreases the 
quality of life of these patients (2, 4). Current treatments for hyposalivation are limited to 
saliva substitutes in the form of gels or sprays and medications, such as the muscarinic 
receptor agonists pilocarpine and cevimeline, which induce saliva secretion from residual 
salivary gland cells. However, these treatments are largely ineffective due to their 
transient nature or systemic side effects that are poorly tolerated by many patients (3, 
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106). Therefore, the development of new therapeutic approaches to treat salivary 
hypofunction is a necessity. Experimental approaches for restoring salivary gland 
function have been considered, including gene therapy to augment the expression of 
proteins involved in saliva secretion (28, 82, 104). An alternative approach to regain the 
function of salivary glands is to induce the proliferation, migration, and differentiation of 
residual cells in the damaged salivary glands to promote tissue regeneration (59). This 
approach can be further applied to bioengineer artificial salivary glands that closely 
resemble the native organ in both structure and function (59). 
Reconstitution studies, using salivary gland tissue isolated from embryonic mice (118) 
and humans (90) or human salivary gland progenitor (SGP) cells (84), have demonstrated 
the ability of dissociated cells to migrate towards each other and self-organize into 
acinar-like aggregates with structural features and differentiation markers that resemble 
the native gland. Cellular mechanisms and components that enhance the formation of 
these acinar-like aggregates would likely be important factors in salivary gland 
reconstitution and regeneration. In this study, we investigated the role in salivary gland 
reconstitution/regeneration of the P2Y2 nucleotide receptor (P2Y2R) for extracellular 
ATP and UTP, since previous findings have suggested roles for the P2Y2R in corneal 
epithelia wound healing by inducing cell migration (119), liver regeneration by 
promoting hepatocyte proliferation (8), inflammatory bowel disease by enhancing 
epithelial repair (27), intestinal reepithelialization following experimental colitis (26), 
and reduction of infarct size following myocardial infarction (20). In addition, the P2Y2R 
is upregulated upon disruption of salivary gland tissue homeostasis (113) and in salivary 
glands of the NOD.B10 mouse model of SS-like autoimmune exocrinopathy (99). In a 
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classic model of salivary gland regeneration, P2Y2R expression and activity increase due 
to tissue atrophy caused by a 3-day ductal ligation in rat submandibular gland (SMG), 
whereas P2Y2R expression and activity levels and glandular morphology resemble 
unligated controls 14 days after deligation (1). Collectively, these findings suggest that 
P2Y2R upregulation plays a role in salivary gland regeneration. 
The P2Y2R has structural motifs that enable interactions with diverse signaling pathways, 
such as Src homology 3 binding domains that mediate transactivation of growth factor 
receptors (76) and an Arg-Gly-Asp (RGD) domain that binds directly to αVβ3/5 integrins 
to activate the Rho and Rac GTPases and cytoskeletal rearrangements (6, 34, 74). P2Y2R 
activation also has been shown to induce downstream activation of MAPKs, including 
JNK (29, 110) and ERK1/2 (13, 29, 94), in several cell types. The P2Y2R also has been 
shown to activate metalloproteases that induce epidermal growth factor (EGF) receptor 
(EGFR) and ErbB3 phosphorylation in human salivary gland (HSG) cells (94). P2Y2R 
interactions and signaling pathways enable extracellular ATP and UTP to regulate 
numerous physiological processes, such as cell proliferation, migration, and 
differentiation (6, 12, 14, 34, 87, 117, 119, 125). 
On the basis of the role of the P2Y2R in the regulation of intracellular signaling pathways 
that are crucial to tissue repair, we investigated whether the P2Y2R plays a similar role in 
the salivary gland using in vitro and ex vivo approaches. Our goals were to test whether 
P2Y2R activation enhances the aggregation and self-organization of dispersed salivary 
epithelial cells into acinar-like aggregates and to determine the underlying mechanisms. 
We found that P2Y2R-mediated formation of acinar-like spheres involves the 
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transactivation of the EGFR through activation of the metalloproteases 
ADAM10/ADAM17 and the α5β1 integrin/Cdc42 Rho GTPase signaling pathway, 
leading to downstream activation of MAPKs. 
In the following studies, we used the rat parotid acinar (Par-C10) cell line, an established 
in vitro model of salivary gland differentiation and function (7, 112). Par-C10 cells 
express endogenous P2Y2Rs, but not P2Y4R (unpublished observations) or P2Y6R (112). 
Therefore, P2Y2R is the only P2Y or P2X receptor subtype that responds to UTP in these 
cells (112). Unlike the majority of salivary cell lines, including HSG cells, Par-C10 cells 
are able to differentiate on Matrigel into three-dimensional (3D) acinar-like spheres that 
display characteristics similar to differentiated acini in salivary glands, including cell 
polarization and tight junction formation, which are required to maintain the 
transepithelial potential difference and responsiveness to muscarinic receptor agonists 
(7). In addition, we used primary SMG cells isolated from wild-type and P2Y2R
−/−
 mice 
to corroborate the results obtained with Par-C10 cells. 
MATERIALS AND METHODS 
Reagents.  
All reagents were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise noted. 
Par-C10 cell culture.  
Par-C10 cells transfected with cDNA encoding the green fluorescent protein (GFP)-
tagged human P2Y2R (GFP-hP2Y2R) (7) were cultured in a 1:1 mixture of DMEM-
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Ham's F-12 medium (Life Technologies, Grand Island, NY) supplemented with 2.5% 
(vol/vol) fetal bovine serum (FBS) (Life Technologies), insulin (5 μg/ml), transferrin (5 
μg/ml), selenite (5 ng/ml), retinoic acid (0.1 μM), EGF (80 ng/ml) (Calbiochem, 
Billerica, MA), triiodothyronine (2 nM), hydrocortisone (1.1 μM), glutamine (5 mM), 
gentamicin (50 μg/ml), cholera toxin (8.4 ng/ml), and G418 (0.5 mg/ml) (Mediatech, 
Manassas, VA) and maintained at 37°C in a humidified atmosphere of 5% CO2 and 95% 
air. 
Mice.  
C57BL/6 (wild-type) and P2Y2R
−/−
 mice on a C57BL/6 background were purchased from 
Jackson Laboratories (Bar Harbor, ME) and bred at the Christopher S. Bond Life 
Sciences Center Animal Facility of the University of Missouri, Columbia, MO. Animals 
were housed in vented cages with 12:12-h light-dark cycles and received food and water 
ad libitum. All animals were handled using protocols approved by the Institutional 
Animal Care and Use Committee (IACUC) of the University of Missouri. 
Preparation of dispersed cell aggregates from mouse SMG.  
Dispersed cell aggregates from the SMGs of wild-type C57BL/6 and P2Y2R
−/−
 mice were 
prepared, as previously described (94). Briefly, the mice were anesthetized with 
isoflurane and the SMGs were removed. The glands were finely minced and incubated in 
dispersion medium consisting of DMEM-Ham's F-12 medium (1:1), 0.2 mM CaCl2, 1% 
(wt/vol) bovine serum albumin (BSA), 50 U/ml collagenase (Worthington Biochemical, 
Freehold, NJ), and 400 U/ml hyaluronidase at 37°C for 40 min with aeration (95% air 
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and 5% CO2). Cell aggregates in dispersion medium were suspended by pipetting at 20, 
30, and 40 min of the incubation period. The dispersed cell aggregates were washed with 
enzyme-free assay buffer (in mM: 120 NaCl, 4 KCl, 1.2 KH2PO4, 1.2 MgSO4, 1 CaCl2, 
10 glucose, 15 HEPES, pH 7.4) containing 1% (vol/vol) FBS, filtered through nylon 
mesh, and cultured in DMEM-Ham's F-12 medium (1:1) containing 2.5% (vol/vol) FBS 
and the following supplements: retinoic acid (0.1 μM), EGF (80 ng/ml), triiodothyronine 
(2 nM), hydrocortisone (1.1 μM), glutamine (5 mM), insulin (5 μg/ml), transferrin (5 
μg/ml), selenite (5 ng/ml), gentamicin (50 μg/ml), and cholera toxin (8.4 ng/ml). The 
cells were cultured at 37°C in a humidified atmosphere of 95% air and 5% CO2. 
Migration assay.  
Par-C10 single-cell suspensions in DMEM/Ham's F-12 medium (1:1) containing 0.1% 
(vol/vol) FBS were seeded (2 × 10
5
 cells/well) on a 24-well plate coated with growth 
factor reduced (GFR) Matrigel (BD Biosciences, San Jose, CA) and incubated at 37°C in 
a humidified atmosphere of 5% CO2 and 95% air for 4 h. Then, the cell culture plate was 
mounted on a Nikon Eclipse Ti-E microscope equipped with a digital camera, a 
motorized x-y stage, an automatic shutter, and an in vivo incubation chamber (37°C, 5% 
CO2, and 95% air). Within each well, a field of cells was located with a ×10 objective and 
marked for monitoring over the duration of the experiment using Nikon NIS-Elements 
imaging software. The exposure time was kept constant for all positions and all time 
points. Cells were treated with or without UTP (100 μM) or EGF (100 ng/ml). In 
inhibitor studies, cells were pretreated with EGFR inhibitor AG1478 (1 μM) (Cell 
Signaling Technology, Beverly, MA), ADAM10/ADAM17 inhibitor TAPI-2 (10 μM) 
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(Peptides International, Louisville, KY), α5β1 integrin blocking antibody (100 μg/ml) 
(Biolegend, San Diego, CA), Cdc42 inhibitor ML141 (10 μM) (Tocris Bioscience, 
Minneapolis, MN), RhoA inhibitor SR3677 (10 μM) (Tocris Bioscience), MEK/ERK 
pathway inhibitor U0126 (10 μM) (Cell Signaling Technology) or JNK inhibitor 
SP600125 (10 μM) (Tocris Bioscience) for 2 h before UTP, EGF, or vehicle (basal) 
treatment. Unless otherwise noted, inhibitors at the concentrations employed had no 
effect on the responses measured under basal conditions. Transmitted light images of 
cells were obtained every 10 min for the time indicated. Cellular aggregation was 
monitored by manually counting the number of aggregation events, where one 
aggregation event was defined as the coalescence/fusion of two or more cells at the same 
time point. ZO-1 tight junction protein was detected in Par-C10 cell aggregates formed 
after 36 h using immunofluorescence as previously described (7). 
For primary SMG cells isolated from wild-type and P2Y2R
−/−
 mice, SMGs were 
enzymatically dispersed and incubated for 3 days (37°C, 5% CO2, and 95% air) to allow 
the P2Y2R to upregulate. After 3 days, cells were serum-starved overnight and on day 4, 
cells were seeded on GFR-Matrigel for 8 h, treated with or without UTP, and monitored 
by time-lapse live cell imaging, as described above. In inhibitor studies, cells were 
pretreated with EGFR inhibitor AG1478 (1 μM) (Cell Signaling Technology) for 2 h 
before UTP or vehicle (basal) treatment. Primary cell migration was assessed by 
measuring the distance traveled from the origin, total distance traveled, and average 
velocity using the tracking software provided with the NIS-Elements imaging software. 
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SDS-PAGE and Western blot analysis.  
Par-C10 cells (2 × 10
5
 cells/well) were seeded on 24-well culture dishes, grown to 70% 
confluence, and then incubated overnight in DMEM-Ham's F-12 medium (1:1) without 
serum. When indicated, the cells were pretreated with or without inhibitors for 2 h at 
37°C before stimulation with agonists for the indicated times. Then, the medium was 
removed and 100 μl of 2× Laemmli lysis buffer [20 mM NaH2PO4, pH 7.0, 20% (vol/vol) 
glycerol, 4% (wt/vol) SDS, 0.01% (wt/vol) bromophenol blue, and 100 mM 
dithiothreitol] were added. The samples were sonicated for 5 s with a Branson Sonifier 
250 (microtip; output level, 5; duty cycle, 50%), heated at 95°C for 5 min, and subjected 
to SDS-PAGE on 7.5% (wt/vol) polyacrylamide gels. The proteins resolved on the gel 
were transferred to nitrocellulose membranes and blocked for 1 h with 5% (wt/vol) 
nonfat dry milk in Tris-buffered saline containing 0.1% (vol/vol) Tween 20 (TBST). The 
blots were incubated overnight at 4°C in blocking solution or TBST with the following 
rabbit polyclonal antibodies used at 1:1,000 dilutions: anti-phospho-EGFR (Tyr1068) 
(Cell Signaling Technology), anti-phospho-JNK (Thr183/Tyr185) (Cell Signaling 
Technology), anti-phospho-ERK1/2 (Thr202/Tyr204) (Cell Signaling Technology) or 
anti-ERK1/2 (Santa Cruz Biotechnology, Santa Cruz, CA) as a loading control. The 
membranes were washed three times with TBST and incubated with horseradish 
peroxidase-linked goat anti-rabbit IgG antibody (1:2,000 dilution; Santa Cruz 
Biotechnology) at room temperature for 1 h. The membranes were washed three times 
with TBST and incubated with enhanced chemiluminescence reagent, and the protein 
bands detected on X-ray film were quantified using a computer-driven scanner and 
Quantity One software (Bio-Rad, Hercules, CA). The intensities of phosphorylated 
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protein bands in cells treated with agonists or other agents were normalized to total 
ERK1/2 and are expressed as a percentage of normalized data from untreated controls. 
Cdc42 activation assay.  
A Cdc42 activation assay kit (Cell Biolabs, San Diego, CA) was used to assess Cdc42 
activity according to the manufacturer's instructions. Briefly, Par-C10 cells were cultured 
in 100-mm culture dishes and grown to 70% confluence. Then, cells were starved 
overnight in serum-free DMEM-Ham's F-12 medium (1:1) before being stimulated with 
UTP (100 μM) for the indicated times. Cell lysates were collected using 1× assay/lysis 
buffer (125 mM HEPES, pH 7.5, 750 mM NaCl, 5% NP-40, 50 mM MgCl2, 5 mM 
EDTA, 10% glycerol) and incubated for 1 h at 4°C with p21-activated kinase-1 p21-
binding domain (PAK1 PBD) agarose beads, which bind the GTP-bound form of Cdc42. 
GTP-bound Cdc42 was analyzed by Western analysis using mouse monoclonal anti-rat 
Cdc42 antibody (1:1,000 dilution; Cell Biolabs). The membranes were washed three 
times with TBST and incubated with horseradish peroxidase-linked goat anti-mouse IgG 
antibody (1:2,000 dilution) at room temperature for 1 h. The membranes were washed 
three times with TBST and incubated with enhanced chemiluminescence reagent, and the 
protein bands were detected on X-ray film. 
Reverse transcription and real-time PCR analysis of P2Y2R mRNA expression.  
Total RNA was isolated using the RNeasy Plus Mini Kit (Qiagen, Valencia, CA) from 
SMG aggregates cultured for 0, 24, 48, or 72 h at 37°C in 5% CO2 and 95% air. cDNA 
was synthesized from 1 μg of purified RNA using the Advantage RT for PCR kit 
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(Clontech Laboratories, Mountain View, CA). Ten percent of the synthesized cDNA was 
used as a template in 25 μl real-time PCR reactions, and samples were run in duplicate 
for the P2Y2R target and the endogenous 18S RNA control. The relative levels of P2Y2R 
and 18S RNA in each sample were determined and are expressed as a ratio of P2Y2R to 
18S RNA (normalized to 1) using Applied Biosystems software. 
Intracellular free Ca
2+
 concentration measurements.  
Changes in the intracellular free Ca
2+
 concentration ([Ca
2+
]i) in SMG cell aggregates 
were quantified as previously described (99). Briefly, dispersed SMG aggregates from 
wild-type or P2Y2R
−/−
 mice were cultured for 72 h and loaded with 2 μM fura 2-AM 
(Calbiochem) for 30 min at 37°C in assay buffer (in mM: 120 NaCl, 4 KCl, 1.2 KH2PO4, 
1.2 MgSO4, 1 CaCl2, 10 glucose, 15 HEPES, pH 7.4) containing 0.1% (wt/vol) BSA. 
Then, the SMG aggregates were washed and adhered to chambered coverslips coated 
with Cell-Tak (BD Biosciences) for an additional 30 min in the absence of fura 2-AM. 
SMG aggregates were stimulated with UTP (100 μM), and changes in the 340/380 nm 
excitation ratio (505 nm emission) were monitored using an InCyt dual-wavelength 
fluorescence imaging system (Intracellular Imaging, Cincinnati, OH). Fluorescence ratios 
were converted to [Ca
2+
]i (nM) using a standard curve created with known concentrations 
of Ca
2+
. 
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Statistical analysis.  
The quantitative results are presented as the means ± SE of data from three or more 
experiments. Two-tailed t-test or ANOVA followed by Bonferroni or Dunnett's test was 
performed, as indicated, where P < 0.05 represents a significant difference. 
RESULTS 
P2Y2R activation enhances Par-C10 cell aggregation and the formation of acinar-
like spheres.  
When plated on extracellular matrices, such as Matrigel, dispersed salivary epithelial 
cells isolated from embryonic mice (118) or adult humans (90) as well as cultured Par-
C10 (7) and HSG (49) cells migrate towards each other and self-organize into aggregates 
that display structural and/or functional features similar to the native salivary gland. 
Since activation of the P2Y2R has been shown to enhance the migration of a variety of 
cell types (6, 117, 125), including epithelial cells (13, 68), we investigated whether 
P2Y2R activation enhances the migration, aggregation, and self-organization of salivary 
epithelial cells. Par-C10 single-cell suspensions seeded on GFR-Matrigel-coated 24-well 
plates (2 × 10
5
 cells/well) were treated with or without UTP (100 μM), and cells were 
monitored for 36 h by time-lapse live cell imaging (Fig. Appendix I-1A), as described in 
materials and methods. During the first 2 h of the time course, UTP-treated single Par-
C10 cells showed enhanced migratory responses, as indicated by the distance that single 
cells traveled from the origin (Fig. Appendix I-1B), the total distance that cells migrated 
(Fig. Appendix I-1C), and the increase in the cell velocity (Fig. Appendix I-1D). After 2 
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h, single Par-C10 cells began to form aggregates that were quantified, as described in 
materials and methods, where one aggregation event represents the coalescence/fusion of 
two or more cells at the same time point. UTP-treated Par-C10 cells exhibited enhanced 
aggregation (Fig. Appendix I-1, A and E, and Supplemental Movies S1 and S2; 
Supplemental Material for this article is available online at the journal website) with 
100% forming acinar-like spheres that display lumen formation and an organized 
distribution of the tight junction protein ZO-1 (Fig. Appendix I-1F) at the end of 36 h. 
Although untreated (basal) Par-C10 cells can aggregate and express ZO-1, they did not 
form differentiated acinar-like spheres until ∼72 h in culture (data not shown), as 
previously described (7). Notably, the majority of aggregation events took place in the 
first 12 h after addition of UTP (Fig. Appendix I-1G). Therefore, subsequent experiments 
investigating aggregation events were performed for 12 h. 
Inhibition of EGFR decreases UTP-induced Par-C10 cell aggregation.  
EGFR regulates a wide variety of cellular responses, including cell migration and 
differentiation (47, 57). In HSG cells, the P2Y2R has been shown to activate EGFR (94). 
To determine whether UTP-induced enhancement of Par-C10 cell aggregation is 
dependent on EGFR activation, cells were pretreated with AG1478 (1 μM), a potent 
EGFR inhibitor, 2 h prior to UTP stimulation. The results show that EGFR inhibition 
decreased UTP-induced Par-C10 cell aggregation by 69% (Fig. Appendix I-2A) and, as 
expected, completely inhibited EGF-induced enhancement of Par-C10 cell aggregation 
(Fig. Appendix I-2A). EGFR inhibition also prevented UTP- and EGF-induced 
phosphorylation of the EGFR (Fig. Appendix I-2B). 
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Inhibition of ADAM10/ADAM17 metalloproteases decreases UTP-induced Par-C10 
cell aggregation and EGFR phosphorylation.  
In HSG cells, the P2Y2R has been shown to activate EGFR via ADAM10 and ADAM17 
metalloproteases (94) that promote shedding of EGF-like ligands, such as neuregulin, 
which bind to and activate members of the EGFR family. To determine whether 
ADAM10/ADAM17 are involved in the UTP-induced enhancement of Par-C10 cell 
aggregation, cells were pretreated with the selective ADAM10/ADAM17 inhibitor TAPI-
2 (10 μM), which partially (52%) decreased UTP-induced Par-C10 cell aggregation (Fig. 
Appendix I-3A), whereas ADAM10/ADAM17 inhibition did not affect the EGF-induced 
increase in aggregation (Fig. Appendix I-3A). Consistent with the role of 
metalloproteases in the P2Y2R-mediated generation of EGFR agonists (94), 
ADAM10/ADAM17 inhibition decreased UTP-induced, but not EGF-induced, 
phosphorylation of the EGFR (Fig. Appendix I-3B). The partial loss of UTP-induced Par-
C10 cell aggregation by ADAM10/ADAM17 inhibition suggests that other P2Y2R-
mediated signaling pathways contribute to the cell aggregation response. 
Inhibition of the α5β1 integrin/Cdc42 signaling pathway decreases UTP-induced 
Par-C10 cell aggregation and EGFR phosphorylation.  
The P2Y2R contains an extracellular-oriented RGD sequence that interacts with RGD-
binding integrins (35) to activate Rho GTPases that regulate cell migration (6, 117). The 
RGD-binding α5β1 integrin has been shown to regulate SMG branching morphogenesis 
(96) and stimulate migration of a variety of cell types (16, 22, 42, 51, 69, 73, 115). To 
test whether UTP-induced Par-C10 cell migration and aggregation require activation of 
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α5β1 integrin, cells were pretreated with α5β1 integrin function-blocking antibody (100 
mg/ml) prior to addition of 100 μM UTP. Results indicate that inhibition of α5β1 integrin 
function decreased UTP-induced aggregation by 49%, but had no effect on the EGF-
induced response (Fig. Appendix I-4A). Integrin-dependent activation of the Rho 
GTPases Cdc42, Rac1, and RhoA has been shown to modulate cytoskeletal 
reorganization and cell migration, where there is a reciprocal relationship between 
Cdc42/Rac1 and RhoA activities (32, 75, 97). Our results show that stimulation of Par-
C10 cells with 100 μM UTP activates Cdc42 in a time-dependent manner (Fig. Appendix 
I-4B, top). Inhibition of Cdc42 with the selective antagonist ML141 (10 μM) inhibited 
UTP-induced aggregation by 90% (Fig. Appendix I-4B, bottom) and inhibited the UTP-
induced phosphorylation of EGFR to a similar extent (Fig. Appendix I-4D), but it had no 
effect on EGF-induced responses, which are independent of metalloproteases (Fig. 
Appendix I-3) and α5β1 integrin/Cdc42 (Figs. Appendix I-4, A, B, and D). However, 
inhibition of RhoA with SR3677 (10 μM) significantly increased basal cell aggregation 
by almost twofold and had no additional effect on the UTP- or the EGF-induced 
enhancement of Par-C10 cell aggregation (Fig. Appendix I-4C). Inhibition of Rac1 using 
NSC23766 (100 μM) did not affect UTP-induced or basal Par-C10 cell aggregation (data 
not shown). These data suggest that the P2Y2R-mediated activation of the α5β1 
integrin/Cdc42 signaling pathway enhances the self-organization of Par-C10 cells into 
acinar-like spheres through the activation of the EGFR pathway. Moreover, these data 
show that RhoA plays an inhibitory role in the basal aggregation of dispersed Par-C10 
cells. 
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UTP-induced Par-C10 cell aggregation depends on the activation of JNK and 
ERK1/2.  
The activation of the EGFR leads to downstream activation of the MAPKs ERK1/2 and 
JNK, a response shown to modulate cell migration (18). Initially, we determined that 
P2Y2R activation with 100 μM UTP stimulates the time-dependent phosphorylation of 
JNK and ERK1/2 in Par-C10 cells (Fig. Appendix I-5A). Inhibition of JNK with 10 μM 
SP600125 or ERK1/2 with 10 μM U0126, a MEK inhibitor, decreased UTP-induced Par-
C10 cell aggregation (Fig. Appendix I-5B), suggesting that JNK and ERK1/2 are 
regulators of Par-C10 acinar-like sphere formation. The EGFR pathway is apparently 
involved in the regulation of JNK- and ERK1/2-dependent Par-C10 cell aggregation 
induced by 100 μM UTP, since inhibition of the EGFR with 1 μM AG1478 (Fig. 
Appendix I-5C) significantly reduced UTP-induced JNK and ERK1/2 phosphorylation. 
UTP stimulates the migration of primary murine SMG cells from wild-type but not 
P2Y2R
−/−
 mice.  
To test whether the UTP-induced salivary epithelial cell migration and aggregation are 
mediated by the P2Y2R, SMGs from wild-type and P2Y2R
−/−
 mice were isolated, 
enzymatically dispersed, and cultured for 3 days to allow for upregulation of the P2Y2R, 
as previously described (113). Similar to primary rat SMG cell aggregates (113), P2Y2R 
mRNA expression is upregulated with time in cells cultured from wild-type mice (Fig. 
Appendix I-6A), consistent with an increase in the [Ca
2+
]i induced by UTP in these cells 
(Fig. Appendix I-6B), responses not seen in SMG cell aggregates from P2Y2R
−/−
 mice 
(data not shown). UTP (100 μM) stimulated the migration of SMG cell aggregates from 
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wild-type but not P2Y2R
−/−
 mice (Fig. Appendix I-6C). UTP-induced migration of wild-
type primary SMG cells occurred only during the first 4 h, as indicated by the distance 
that cell aggregates traveled from the origin (Fig. Appendix I-6D), the total distance that 
cell aggregates migrated (Fig. Appendix I-6E), and an increase in the velocity of the cell 
aggregates (Fig. Appendix I-6F). A lack of these responses in SMG from P2Y2R
−/−
 mice 
(Fig. Appendix I-6, C–F) confirms that UTP-induced SMG cell migration is mediated by 
P2Y2R activation. Furthermore, inhibition of EGFR with 1 μM AG1478 impaired the 
UTP-induced migratory responses in wild-type primary SMG cells (Fig. Appendix I-7), 
corroborating our findings using Par-C10 cells that the P2Y2R-induced responses are 
dependent on EGFR activation. 
DISCUSSION 
Recent progress has been made in the development of strategies for regeneration and 
engineering of a variety of tissues, including skin (79, 92), corneal epithelium (43), 
cartilage (85), bone (10, 11), bladder (77), and lacrimal (48) and salivary glands (83). 
Determining the capacity of dispersed cells or tissue fragments to reassemble into native 
structures and the underlying mechanisms involved should provide novel insights to 
improve tissue regeneration approaches. The capacity of dispersed salivary epithelial 
cells or salivary gland-derived progenitor cells to reassemble into acinar-like spheres or 
branching structures has been previously assessed (84, 90, 118), but little is known about 
the signaling events involved in these differentiation processes. In the present study, we 
determined that the P2Y2 nucleotide receptor (P2Y2R), known to be upregulated during 
salivary gland damage and disease (1, 99, 113), plays a role in the aggregation and self-
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organization of dispersed salivary epithelial cells into acinar-like spheres. Our in vitro 
data using the rat parotid acinar (Par-C10) cell line show that P2Y2R activation by UTP 
significantly enhances the migration, aggregation, and self-organization of dispersed Par-
C10 cells into acinar-like spheres (Fig. Appendix I-1, A–E, and Supplemental Movies S1 
and S2) that display structural features and differentiation markers similar to those of 
acini in the native gland (Fig. Appendix I-1F), as previously described (7). In addition, 
our ex vivo data show that P2Y2R deletion prevents the UTP-induced migration of 
primary murine SMG cell aggregates (Fig. Appendix I-6), demonstrating that UTP-
induced migratory responses of salivary epithelial cells are primarily mediated by P2Y2R 
activation. 
In this paper, we demonstrate that UTP-induced enhancement of dispersed salivary 
epithelial cell aggregation occurs by two distinct signaling pathways coupled to 
activation of the P2Y2R: 1) the activation of metalloproteases (i.e., ADAM10/ADAM17) 
and 2) the activation of the α5β1 integrin/Cdc42 Rho GTPase pathway, major signaling 
pathways that activate various physiological processes (5, 95, 101, 108, 109, 116, 123, 
128). Both of these signaling pathways activate EGFR, which leads to the downstream 
activation of JNK and ERK1/2 that we demonstrate increases UTP-induced aggregation 
of Par-C10 cells. A schematic outlining these P2Y2R-mediated signaling pathways 
involved in salivary epithelial cell migration and aggregation is shown in Fig. Appendix 
I-8. 
It is well-established that the EGFR and its signaling pathways are critical for stimulating 
cell migration and the regeneration of a variety of tissues (30, 37, 57, 58, 81, 91). In 
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salivary tissue reconstitution studies, exogenous EGF has been shown to be crucial for 
the self-organization of dispersed salivary gland-derived progenitor cells into branching 
structures (84). Several studies have shown that P2Y2R activation enhances epithelial cell 
migration, thereby accelerating wound healing and tissue regeneration (9, 12–14, 26, 62, 
68) in part due to transactivation of the EGFR (12, 14, 62, 68). Our group has previously 
shown that the P2Y2R mediates transactivation of the EGFR in HSG cells through 
metalloprotease-dependent neuregulin release (94). In the present study, we demonstrate 
that the ADAM10/ADAM17/EGFR signaling pathway is required for P2Y2R-mediated 
aggregation of salivary epithelial cells (Figs. Appendix I-2, -3 and -8), suggesting P2Y2R 
as a potential therapeutic target for promoting salivary gland regeneration or the ex vivo 
bioengineering of salivary glands, which represent promising alternative approaches to 
replace the current ineffective therapies for hyposalivation resulting from SS or 
irradiation therapy for head and neck cancers. 
In addition to metalloprotease-dependent activation of the EGFR, the P2Y2R can activate 
EGFR through the α5β1 integrin/Cdc42 signaling pathway (Fig. Appendix I-4). Our group 
has previously shown that the P2Y2R contains an RGD motif in its first extracellular loop 
that enables receptor interaction with RGD-binding αVβ3/5 integrins to stimulate cell 
migration (6, 26, 64, 117). However, P2Y2R interactions with other RGD-binding 
integrins have not been previously reported. In this study, we show for the first time that 
the α5β1 integrin, a known mediator of SMG branching morphogenesis (96), cell 
migration, and tissue regeneration (16, 40–42, 51, 66, 67, 69, 73, 78, 88, 115, 121, 127), 
also plays a role in P2Y2R-mediated salivary epithelial cell aggregation (Fig. Appendix I-
4A). We also have shown that the P2Y2R/αV integrin interaction leads to the activation of 
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Rac (6), a Rho GTPase critical for regulating cell migration (39, 44–46, 93, 98), epithelial 
morphogenesis (44, 114), and salivary acinar formation (23). In this study, we found no 
evidence that Rac1 is required for P2Y2R-mediated salivary epithelial cell aggregation 
(data not shown), but rather Cdc42, another Rho GTPase known to regulate cell 
migration (38, 39, 44–46, 93, 98) and tissue regeneration (89, 126), regulates the 
aggregatory response to P2Y2R activation (Fig. Appendix I-4B). Previous reports from 
our lab have linked P2Y2R-mediated cell migration to the activation of the Rho GTPase 
RhoA, as well as Rac1 (6, 64, 74, 103). Interestingly, RhoA inhibition in Par-C10 
salivary epithelial cells increased basal cell aggregation by almost twofold and had no 
additional effect on the UTP- or EGF-induced enhancement of cell aggregation (Fig. 
Appendix I-4C), suggesting that RhoA GTPase is a negative regulator of migratory 
responses in these cells. A reciprocal relationship between Cdc42 and RhoA has recently 
been described for mammary epithelial acinar morphogenesis (32). In contrast, another 
study has shown that inhibition of RhoA does not affect acinus formation by HSG cells 
(23). 
It is well-established that MAPKs, including JNK and ERK1/2, regulate cell 
proliferation, migration, and differentiation (15, 18, 21, 36, 63, 72, 86, 102, 120), 
processes important for salivary gland morphogenesis (60, 70) and regeneration of a wide 
variety of tissues (19, 24, 50, 53, 54, 56, 65, 71, 80, 100, 105, 107, 111, 122, 124). The 
P2Y2R-mediated activation of ERK1/2 has been reported in HSG cells (94), corneal 
epithelial cells (13), and human coronary artery endothelial cells (HCAEC) (29). 
However, the ability of the P2Y2R to activate JNK has only been reported for HCAEC 
(29) and primary rat hepatocytes (110). Our data indicate that the P2Y2R agonist UTP 
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activates JNK and ERK1/2 (Fig. Appendix I- 5A) through the canonical EGFR pathway 
(Fig. Appendix I-5C) to enhance salivary epithelial cell aggregation and self-organization 
(Fig. Appendix I-5B). 
Growth factor receptors and integrins represent major signaling pathways that interact at 
different levels to regulate various physiological processes (33, 55). The present study 
indicates that the P2Y2R transactivates the EGFR through the α5β1 integrin/Cdc42 
signaling pathway as well as the activation of the metalloproteases ADAM10/ADAM17, 
enabling extracellular nucleotides to enhance the aggregation and self-organization of 
dispersed salivary epithelial cells into acinar-like spheres on GFR-Matrigel by increasing 
the activities of the MAPKs JNK and ERK1/2. Further work is needed to investigate 
whether other P2Y2R signaling pathways are involved in acinar-like sphere formation, 
such as the activation of the MAPK p38 that has been reported to promote the 
regeneration of salivary glands (24), skeletal muscle (17), and sciatic nerve (61) and to 
regulate corneal epithelial wound healing (105). Other potential P2Y2R signaling 
pathways involved in salivary epithelial cell migration include the activation of 
phosphatidylinositol-3-kinase (PI3-K)/protein kinase B (Akt) (117) and the Go signaling 
pathway (6). Understanding the signaling events responsible for the aggregation and self-
organization of dispersed salivary epithelial cells into acinar-like spheres should provide 
insights into novel approaches for the bioengineering of salivary glands (83) and should 
lead to better regenerative/replacement strategies for salivary glands damaged in human 
autoimmune diseases or as an unintended side effect of radiation treatments for head and 
neck cancers. 
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FIGURES 
Fig. Appendix I-1. UTP enhances Par-C10 cell aggregation and the formation of 
acinar-like spheres on growth factor reduced (GFR) Matrigel. A: Par-C10 single-cell 
suspensions were cultured on GFR-Matrigel for 4 h, then treated with or without UTP 
(100 μM) and monitored by time-lapse live cell imaging for 36 h, as described in 
materials and methods. B–D: the migration of single Par-C10 cells was monitored for 2 h, 
and the distance migrated from the origin (B), total distance traveled (C), and average 
velocity of single cells (D) were quantified with the tracking software provided with NIS-
Elements imaging software. The data represent the means ± SE of results from at least 3 
experiments. *P < 0.05, significant increase over basal levels (two-tailed t-test). E: 
quantification of the number of aggregation events in response to UTP (100 μM) after 36 
h. F: after 36 h, UTP-treated Par-C10 cell aggregates formed acinar-like spheres that 
display lumen formation and an organized distribution of the tight junction protein ZO-1 
(red) detected by immunofluorescence using rabbit anti-ZO-1 antibody, as previously 
described (7), features not observed in the Par-C10 cell aggregates formed under basal 
conditions. G: quantification of the aggregation events from 0–12 h, 12–24 h, and 24–36 
h indicates that the majority of aggregation events take place in the first 12 h with or 
without UTP treatment. The data shown represent the means ± SE of results from at least 
3 experiments. *P < 0.05, significant increase over basal levels (two-tailed t-test). 
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Fig. Appendix I-2. Inhibition of epidermal growth factor (EGF) receptor (EGFR) 
activation decreases UTP-induced enhancement of Par-C10 cell aggregation. A: Par-
C10 single-cell suspensions plated on GFR-Matrigel for 4 h were pretreated with or 
without the EGFR inhibitor AG1478 (1 μM) for 2 h, then incubated with or without UTP 
(100 μM) or EGF (100 ng/ml). Par-C10 cell aggregates were monitored by time-lapse 
live cell imaging for 12 h. The data are expressed as percentages of the maximal number 
of aggregation events induced by UTP or EGF in the absence of AG1478 and represent 
the means ± SE of results from at least 3 experiments. **P < 0.01, ***P < 0.001, 
significant difference from the UTP- or EGF-induced response (two-tailed t-test). B: Par-
C10 cells were serum-starved overnight, pretreated with or without AG1478 (1 μM) for 2 
h, and then treated with or without UTP (100 μM) or EGF (100 ng/ml). Five minutes 
after UTP or EGF addition, protein extracts were prepared from Par-C10 cell aggregates 
and EGFR phosphorylation (Y1068) was determined by Western analysis. Representative 
blots are shown (top). Quantification of protein levels in blots (bottom) was performed 
using Quantity One software, as described in materials and methods. The data are 
expressed as the percentage increase in EGFR phosphorylation induced by UTP or EGF, 
compared with untreated controls, and represent the means ± SE of results from at least 3 
experiments. *P < 0.05, ***P < 0.01, significant difference from the UTP- or EGF-
induced response (two-tailed t-test). 
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Fig. Appendix I-3. Inhibition of metalloproteases ADAM10/ADAM17 decreases 
UTP-induced enhancement of Par-C10 cell aggregation and EGFR phosphorylation. 
A: Par-C10 single-cell suspensions plated on GFR-Matrigel for 4 h were pretreated with 
or without the ADAM10/ADAM17 inhibitor TAPI-2 (10 μM) for 2 h, then incubated 
with or without UTP (100 μM) or EGF (100 ng/ml). Par-C10 cell aggregates were 
monitored by time-lapse live cell imaging for 12 h. The data are expressed as percentages 
of the maximal number of aggregation events induced by UTP or EGF in the absence of 
TAPI-2 and represent the means ± SE of results from at least 3 experiments. ***P < 
0.001, significant difference from the UTP- or EGF-induced response (two-tailed t-test). 
B: Par-C10 cells were serum-starved overnight, pretreated with or without TAPI-2 (10 
μM) for 2 h, and then treated with or without UTP (100 μM) or EGF (100 ng/ml). Five 
minutes after UTP or EGF addition, protein extracts were prepared from Par-C10 cell 
aggregates and EGFR phosphorylation (Y1068) was determined by Western analysis. 
Representative blots are shown (top), where a black line represents noncontiguous lanes 
from the same gel. Quantification of protein levels in blots (bottom) was performed using 
Quantity One software, as described in materials and methods. The data are expressed as 
the percentage increase in EGFR phosphorylation induced by UTP or EGF, compared 
with untreated controls, and represent the means ± SE of results from at least 3 
experiments. **P < 0.01, significant difference from the UTP- or EGF-induced response 
(two-tailed t-test). 
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Fig. Appendix I-4. Inhibition of the α5β1/Cdc42 signaling pathway decreases UTP-
induced Par-C10 cell aggregation and EGFR phosphorylation, whereas RhoA inhibition 
increases basal cell aggregation. Par-C10 single-cell suspensions were plated on GFR-
Matrigel for 4 h, pretreated for 2 h with or without α5β1 integrin function-blocking 
antibody (100 μg/ml) (A), the Cdc42 inhibitor ML141 (10 μM) (B, bottom), or the RhoA 
inhibitor SR3677 (10 μM) (C). Cells were then treated with or without UTP (100 μM) or 
EGF (100 ng/ml), as indicated, and cell aggregation was monitored by time-lapse live 
cell imaging for an additional 12 h. The data are expressed as percentages of the maximal 
number of aggregation events induced by UTP or EGF (A and B) or the total number of 
aggregation events (C). The data represent the means ± SE of results from at least 3 
experiments. A and B: *P < 0.05, **P < 0.01, significant difference from the UTP- or 
EGF-induced response (two-tailed t-test). C: two-way ANOVA was performed followed 
by the Bonferroni test. *P < 0.05, **P < 0.01, significant difference in the number of 
aggregation events between SR3677-treated and untreated cells under basal conditions or 
SR3677-treated cells stimulated with or without UTP or EGF, as indicated. B, top: GTP 
binding by Cdc42 was determined in serum-starved Par-C10 cells treated with or without 
UTP (100 μM) for 1, 5, or 10 min, as described in materials and methods. D: Par-C10 
cells were serum-starved overnight, pretreated with or without the Cdc42 inhibitor 
ML141 (10 μM) for 2 h, and then treated with or without UTP (100 μM) or EGF (100 
ng/ml) for 5 min. EGFR phosphorylation (Y1068) was determined by Western analysis. 
A representative blot is shown (top), where a black line represents noncontiguous lanes 
from the same gel. Quantification of protein levels in blots (bottom) was performed using 
Quantity One software, as described in materials and methods. The data are expressed as 
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the percentage increase in EGFR phosphorylation induced by UTP, compared with 
untreated controls, and represent the means ± SE of results from at least 3 experiments. 
*P < 0.05, significant difference from the UTP-induced response (two-tailed t-test). 
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Fig. Appendix I-5. UTP-induced enhancement of Par-C10 cell aggregation is 
dependent on the activation of JNK and ERK1/2 by the EGFR. A: Par-C10 cells were 
serum-starved overnight and treated with or without 100 μM UTP for 1, 5, 10, or 15 min. 
Protein extracts were subjected to SDS-PAGE, and p-JNK (Thr183/Tyr185), p-ERK1/2 
(Thr202/Tyr204), and ERK1/2 (loading control) were detected by Western analysis. B: 
Par-C10 single-cell suspensions plated on GFR-Matrigel for 4 h were pretreated with or 
without the JNK inhibitor SP600125 (10 μM) or the MEK/ERK inhibitor U0126 (10 μM) 
for 2 h. Cells were then treated with or without UTP (100 μM), and cell aggregation was 
monitored by time-lapse live cell imaging for 12 h. The data are expressed as percentages 
of the maximal number of aggregation events induced by UTP and represent the means ± 
SE of results from at least 3 experiments. **P < 0.01, ***P < 0.001, significant 
difference from the UTP-induced response (two-tailed t-test). C: Par-C10 cells were 
pretreated for 2 h with or without the EGFR inhibitor AG1478 (1 μM) then treated with 
or without UTP (100 μM) for 5 min. Protein extracts were subjected to SDS-PAGE, and 
p-JNK (Thr183/Tyr185), p-ERK1/2 (Thr202/Tyr204), and ERK1/2 (loading control) 
were detected by Western analysis (representative blots are shown on the left, where a 
black line represents noncontiguous lanes from the same gel). Quantification of protein 
levels was performed (right), as described in materials and methods. The data are 
expressed as the percentage increase in JNK (Thr183/Tyr185) and ERK1/2 
(Thr202/Tyr204) phosphorylation induced by UTP, compared with untreated control, and 
represent the means ± SE of results from at least 3 experiments. *P < 0.05, **P < 0.01, 
significant difference from the UTP-induced response (two-tailed t-test). 
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Fig. Appendix I-6. P2Y2 receptor (P2Y2R) mediates UTP-induced migration of 
primary submandibular gland (SMG) cell aggregates. A: P2Y2R mRNA was isolated 
from SMG cell aggregates from wild-type and P2Y2R
−/−
 mice after 0, 24, 48, or 72 h in 
culture, as described in materials and methods. The data are expressed as fold increase in 
P2Y2R mRNA levels over the 0 time point and represent the means of ± SE of results 
from 4 experiments. *P < 0.05, ***P < 0.001, significant increase in P2Y2R mRNA 
expression, compared with the 0 time point (one-way ANOVA followed by Dunnett's 
test). B: changes in the intracellular free Ca
2+
 concentration ([Ca
2+
]i) induced by 100 μM 
UTP in SMG cell aggregates at 0 and 72 h in culture were determined, as described in 
materials and methods. The data represent the means ± SE of results from 7 experiments. 
***P < 0.001, significant difference from the 0 time point (two-tailed t-test). C: primary 
SMGs isolated from wild-type and P2Y2R
−/−
 mice were enzymatically dispersed and 
incubated for 3 days (37°C, 5% CO2, and 95% air) to enable upregulation of the P2Y2R. 
After 3 days, cells were serum-starved overnight, seeded on GFR-Matrigel for 8 h, and 
treated with or without 100 μM UTP. Cell aggregates of similar size were monitored by 
time-lapse live cell imaging for 24 h, and the point of origin (arrow) and the migration 
path (red line) are indicated. D–F: quantification of the distance migrated from the origin 
(D), the total distance traveled (E), and the average velocity (F) of aggregates throughout 
the first 4 h of the time course was performed with the tracking software provided with 
NIS-Elements imaging software. The data represent the means ± SE of results from at 
least 3 experiments. *P < 0.05, significant increase over basal levels (two-tailed t-test). 
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Fig. Appendix I-7. P2Y2R-induced migration of primary SMG cell aggregates is 
dependent on EGFR. Primary SMGs isolated from wild-type and P2Y2R
−/−
 mice were 
enzymatically dispersed and incubated for 3 days (37°C, 5% CO2, and 95% air) to enable 
upregulation of the P2Y2R. After 3 days, cells were serum-starved overnight, seeded on 
GFR-Matrigel for 8 h, and pretreated for 2 h with or without the EGFR inhibitor AG1478 
(1 μM). Cells were then treated with or without UTP (100 μM). Cell aggregates of similar 
size were monitored by time-lapse live cell imaging. Quantification of the distance 
migrated from the origin (A), the total distance traveled (B), and the average velocity (C) 
of aggregates during the first 4 h of the time course was performed with the tracking 
software provided with NIS-Elements imaging software. The data represent the means ± 
SE of results from at least 3 experiments. *P < 0.05, significant decrease from basal 
levels (two-tailed t-test). 
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Fig. Appendix I-8. Proposed mechanisms for P2Y2R-mediated enhancement of 
salivary epithelial cell aggregation and formation of acinar-like spheres. The P2Y2R 
enhances the aggregation of dispersed salivary epithelial cells into acinar-like spheres 
through the activation of the EGFR and subsequent downstream activation of JNK and 
ERK1/2. P2Y2R mediates EGFR activation through two distinct pathways: the first 
pathway involves P2Y2R-mediated activation of matrix metalloproteases (i.e., 
ADAM10/ADAM17), which cleave membrane-bound EGFR ligands (94) leading to the 
activation of the EGFR, and the second pathway involves P2Y2R-mediated activation of 
the Arg-Gly-Asp (RGD) binding α5β1 integrin, which leads to activation of the Rho 
GTPase Cdc42 that also activates the EGFR. RhoA activation has an inhibitory effect on 
the basal aggregation of dispersed Par-C10 salivary epithelial cells. P2Y2R, P2Y2 
receptor; ADAM, a disintegrin and metalloproteinase; GFR, growth factor receptor; 
NRG, neuregulin; EGFR, epidermal growth factor receptor; RhoA, Ras homolog gene 
family member A; Cdc42, cell division control protein 42 homolog. 
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Appendix II 
Increased Expression of TGF-β Signaling Components in a Mouse Model of Fibrosis 
Induced by Submandibular Gland Duct Ligation  
As found in: Woods, L.T., Camden, J.M., El-Sayed, F.G., Khalafalla, M.G., Petris, M.J., 
Erb, L. and Weisman, G.A., 2015. Increased expression of TGF-β signaling components 
in a mouse model of fibrosis induced by submandibular gland duct ligation. PLoS One, 
10(5), p.e0123641. 
Abstract 
Transforming growth factor-β (TGF-β) is a multi-functional cytokine with a well-
described role in the regulation of tissue fibrosis and regeneration in the liver, kidney and 
lung. Submandibular gland (SMG) duct ligation and subsequent deligation in rodents is a 
classical model for studying salivary gland damage and regeneration. While previous 
studies suggest that TGF-β may contribute to salivary gland fibrosis, the expression of 
TGF-β signaling components has not been investigated in relation to mouse SMG duct 
ligation-induced fibrosis and regeneration following ductal deligation. Following a 7 day 
SMG duct ligation, TGF-β1 and TGF-β3 were significantly upregulated in the SMG, as 
were TGF-β receptor 1 and downstream Smad family transcription factors in salivary 
acinar cells, but not in ductal cells. In acinar cells, duct ligation also led to upregulation 
of snail, a Smad-activated E-cadherin repressor and regulator of epithelial-mesenchymal 
transition, whereas in ductal cells upregulation of E-cadherin was observed while snail 
expression was unchanged. Upregulation of these TGF-β signaling components 
correlated with upregulation of fibrosis markers collagen 1 and fibronectin, responses that 
were inhibited by administration of the TGF-β receptor 1 inhibitors SB431542 or 
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GW788388. After SMG regeneration following a 28 day duct deligation, TGF-β 
signaling components and epithelial-mesenchymal transition markers returned to levels 
similar to non-ligated controls. The results from this study indicate that increased TGF-β 
signaling contributes to duct ligation-induced changes in salivary epithelium that 
correlate with glandular fibrosis. Furthermore, the reversibility of enhanced TGF-β 
signaling in acinar cells of duct-ligated mouse SMG after deligation indicates that this is 
an ideal model for studying TGF-β signaling mechanisms in salivary epithelium as well 
as mechanisms of fibrosis initiation and their resolution. 
Introduction 
The salivary glands are exocrine glands that secrete saliva into the oral cavity where 
components of saliva aid in digestion and prevent oral infection [1]. In humans, the 
majority of saliva is secreted from the parotid, submandibular and sublingual glands with 
minor contributions from numerous, small accessory glands. For saliva production, 
activation of muscarinic receptors on the basolateral membrane of acinar cells results in 
fluid secretion into the ductal lumen where the ion content is modulated as saliva travels 
along a series of collecting ducts into the main secretory duct which empties into the oral 
cavity [1]. Salivary dysfunction can significantly decrease quality of life and leads to dry 
mouth, oral infection and poor nutrition [2]. Two primary causes of salivary dysfunction 
in humans are Sjögren’s syndrome (SS), an autoimmune disease characterized by 
lymphocytic infiltration of the salivary gland and production of autoantibodies, and γ-
radiation-induced dysfunction, an unintended consequence of treatment for head and 
neck cancers [3, 4]. Current treatments for salivary hypofunction (i.e., xerostomia) 
include administration of sialogogues and saliva substitutes; however, these approaches 
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are limited to treating the symptom and not the cause of xerostomia [5]. New strategies to 
treat xerostomia are being investigated to regenerate salivary glands and restore normal 
levels of saliva secretion [6, 7]. Understanding the underlying mechanisms of salivary 
gland inflammation in SS and radiation therapy that result in tissue damage could reveal 
novel targets to prevent salivary gland degeneration and promote restoration of functional 
tissue. 
Salivary gland duct ligation and subsequent deligation is a well-studied animal model of 
salivary gland inflammation (ligation) and regeneration (deligation) [8–14]. In this 
model, the main excretory duct of the submandibular gland (SMG) is surgically occluded 
and after a set period of time (~1–30 days) the process is reversed. Within 24 hours of 
duct ligation, immune cells begin to infiltrate the gland and acinar cells begin to atrophy, 
lose expression of acinar proteins and eventually undergo apoptosis [8, 10, 11, 15–17]. 
Ductal cells, subsets of which have been proposed to be salivary progenitor cells that can 
regenerate the gland, remain intact and proliferative during ligation [11, 18, 19]. 
Additionally, ligation causes salivary glands to become fibrotic [20]. Interestingly, once 
the gland is deligated, it begins to regenerate and regains saliva production [12, 14, 21]. 
Studies in rats have demonstrated that SMGs regenerate histologically and functionally 
upon deligation, even after >30 days of duct ligation [21]. The ability of the SMG to 
recover from severe inflammatory and fibrotic events following ligation has made duct 
ligation a useful experimental approach for investigating mechanisms underlying salivary 
gland inflammation and regeneration. 
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Previous studies with liver, lung and kidney have elucidated a key role for transforming 
growth factor-β (TGF-β) in regulating fibrosis and tissue regeneration [22–25]. Three 
isoforms of TGF-β have been identified and denoted as TGF-β1, TGF-β2 and TGF-β3. 
These cytokines are unique in their mechanism of latent activation [26]. TGF-β is 
produced as a proprotein that is proteolytically cleaved into TGF-β and the latency 
associated peptide (LAP). Following cleavage, TGF-β and LAP remain covalently bound 
and LAP forms disulfide bonds with the latent TGF-β binding protein (LTBP). This 
Large Latent Complex (LLC), consisting of TGF-β, LAP and LTBP, is then secreted 
from the cell [26]. The release of active TGF-β from the LLC occurs through proteolytic 
cleavage by matrix metalloproteases, disruption of non-covalent interactions by 
thrombospondin-1 and interaction of LAP with integrins [27–29]. Once TGF-β is 
released, activation of the canonical TGF-β signaling pathway occurs through binding of 
TGF-β to TGF-β receptor 2 (TGF-β R2), which then dimerizes with TGF-β receptor 1 
(TGF-β R1) leading to intracellular phosphorylation and activation of the transcription 
factors Smad2 and Smad3 [30]. Along with Smad4, these transcription factors induce 
cellular responses to extracellular TGF-β by activating several DNA-binding 
transcription factors including Snai1 (Snail) and Snai2 (Slug) [31]. Snail and Slug have 
been well-described as mediators of TGF-β-induced epithelial-mesenchymal transition 
(EMT) [32–34]. Non-canonical TGF-β signaling pathways also have been shown to 
contribute to TGF-β-induced EMT, specifically through the activation of TGF-β-
activated kinase 1 (TAK1) and TAK-1-binding protein (TAB1) [35, 36]. 
EMT is a cellular mechanism by which epithelial cells dedifferentiate from their 
epithelial status to a mesenchymal-like phenotype [37]. This process has been suggested 
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to play a major role in the metastasis of cancer cells, tissue fibrosis and regeneration [38–
40]. During EMT, epithelial proteins such as E-cadherin and zona occludens-1 (ZO-1) are 
downregulated while mesenchymal proteins such as vimentin and α-smooth muscle actin 
(α-SMA) and fibrotic proteins such as fibronectin and collagen 1 are upregulated [41]. 
The cells undergoing EMT then become mesenchymal-like, increasing their capacity for 
migration and redifferentiation. Snail functions in EMT by repressing the expression of 
epithelial E-cadherin [32, 42, 43]. Given the importance of TGF-β signaling to EMT and 
fibrosis and considering previous reports on the role of TGF-β in liver and kidney 
regeneration, we explored whether expression of TGF-β and its downsteam signaling 
proteins is altered in the SMG ligation/deligation model of salivary gland inflammation 
and regeneration. Our results demonstrate increased expression of components of the 
TGF-β signaling pathway in salivary gland epithelium during SMG duct ligation and, 
interestingly, this response is more pronounced in acinar cells compared to ductal cells. 
Furthermore, we found increased expression of E-cadherin and fibrosis markers during 
SMG ligation that, along with proteins in the TGF-β signaling cascade, return to normal 
levels following deligation, which correlates with restoration of normal tissue 
architecture. We further demonstrate that treatment of mice with the TGF-β R1 inhibitors 
SB431542 or GW788388 significantly reduces the upregulation of the fibrosis markers 
collagen 1 and fibronectin caused by SMG duct ligation. Thus, this study demonstrates 
that the SMG ligation/deligation model is an excellent system for investigating reversible 
TGF-β-mediated signaling mechanisms in epithelium as well as mechanisms of 
fibrogenesis and fibrosis resolution. 
Role of P2X7R in Salivary Gland Inflammation 
158 
 
Materials and Methods 
Reagents 
TRIzol Reagent, AlexaFluor 594 goat anti-rabbit IgG antibody, AlexaFluor 594 donkey 
anti-rabbit IgG antibody, AlexaFluor 488 donkey anti-goat IgG antibody and Hoechst 
33258 nuclear stain were purchased from Life Technologies (Grand Island, NY). Rabbit 
anti-aquaporin-5 polyclonal antibody (178615) was purchased from EMD Millipore 
(Billerica, MA). Rat anti-CD45 monoclonal antibody (30-F11) was purchased from 
Biolegend (San Diego, CA). Rabbit anti-TGF-β1/2/3 polyclonal antibody (3771), rabbit 
anti-Smad2/3 monoclonal antibody (D7G7), rabbit anti-phospho-Smad2/3 monoclonal 
antibody (D27F4) and rabbit anti-E-cadherin monoclonal antibody (24E10) were 
purchased from Cell Signaling Technology (Danvers, MA). Rabbit anti-Snail polyclonal 
antibody (NBP1-19529) was purchased from Novus Biologicals (Littleton, CO). Rabbit 
anti-TGF-β R1 polyclonal antibody (H-100), goat anti-aquaporin-5 polyclonal antibody 
(G-19) and horseradish peroxidase-conjugated goat anti-rabbit IgG antibody were 
purchased from Santa Cruz Biotechnology (Santa Cruz, CA). The TGF-β R1 inhibitors 
SB431542 and GW788388 were purchased from Tocris Bioscience (Bristol, United 
Kingdom). All other reagents were purchased from Sigma-Aldrich (St. Louis, MO), 
unless stated otherwise. 
Animals and ethics 
C57BL/6 mice were purchased from Jackson Laboratories (Bar Harbor, ME) and bred at 
the Christopher S. Bond Life Sciences Center Animal Facility of the University of 
Missouri, Columbia, MO. Animals were housed in vented cages with 12 h light/dark 
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cycles and received food and water ad libitum. Age-matched 6–8 week old male mice 
were utilized for all experiments. All surgeries were performed following anesthesia by 
intraperitoneal injection with Avertin (0.75 mg/g mouse weight). Euthanasia was 
performed by terminal anesthesia followed by cervical dislocation and all efforts were 
made to minimize suffering. The protocol for this study was approved by the University 
of Missouri Animal Care and Use Committee (Protocol Number: 7880). 
Ligation and deligation of the SMG main excretory duct 
Unilateral ligation of the SMG main excretory duct was performed as previously 
described [9]. Briefly, mice were anesthetized by intraperitoneal injection with Avertin 
(0.75 mg/g mouse weight) and the main excretory duct on one side of the neck was 
dissected and separated from surrounding connective tissue under a surgical stereoscope. 
The duct was ligated using surgical sutures with particular care taken to avoid ligation of 
surrounding blood vessels and nerves. The incision was closed using surgical clamps and 
the mice were allowed to recover. After 7 days, mice were either subjected to SMG 
deligation or anesthetized with isoflurane in a chamber and euthanized by cervical 
dislocation. For SMG deligation, mice were anesthetized (as above) and, following 
careful dissection of the neck, the surgical suture was removed from the SMG duct and 
the incision was closed using surgical clamps. Following 28 days of recovery, mice were 
anesthetized and euthanized (as above). Then, 7 day-ligated glands with or without a 28 
day deligation and contralateral control glands were excised and processed for real-time 
PCR (RT-PCR), Western analysis or immunofluorescence as described below. For TGF-
β R1 inhibitor studies, mice received intraperitoneal injection of SB431542 (20 mg/kg 
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mouse weight in DMSO), GW788388 (2 mg/kg mouse weight in DMSO) or DMSO only 
as a vehicle control directly after SMG duct ligation and 4 days post-ligation. Seven day 
ligated and contralateral control glands with or without inhibitors were then collected and 
processed for RT-PCR analysis, as described below. 
Real-time PCR 
Ligated, deligated and contralateral control glands were homogenized in TRIzol reagent. 
Following a 5 min incubation at room temperature, chloroform (0.2 ml/ml TRIzol) was 
added and samples were incubated for 5 min at room temperature. Samples were 
centrifuged at 12,000 x g for 15 min at 4°C and RNA isolation from the resulting aqueous 
phase was performed using the RNeasy Plus Mini Kit (Qiagen, Valencia, CA). cDNA 
was prepared from 1 μg of purified RNA using RNA to cDNA EcoDry Premix (Clontech 
Laboratories, Mountain View, CA). Specific Taqman primers for mouse TGF-β1, TGF-
β2, TGF-β3, TAK1 (MAP3K7), TAB1, Snail (Snai1), Slug (Snai2), fibronectin (Fn1), 
collagen 1 (Col1a1), E-cadherin (Cdh1) and 18S were purchased from Applied 
Biosystems (Foster City, CA) and used for RT-PCR on an Applied Biosystems 7500 
Real-Time PCR machine. For data analysis, mRNA expression of target genes was 
normalized to 18S ribosomal RNA as an internal control. 
SDS-PAGE and western blot analysis 
Ligated, deligated and contralateral control SMGs were homogenized in Tissue Protein 
Extraction Reagent (Thermo Scientific, Rockford, IL) containing protease inhibitor 
cocktail (Sigma-Aldrich). Samples were centrifuged at 10,000 x g for 5 min to pellet 
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cellular debris, supernatants were collected and the protein concentration was measured 
using a Nanodrop 1000 spectrophotometer. Following protein concentration 
normalization, samples were combined 1:1 with 2X Laemmli Buffer (20 mM sodium 
phosphate, pH 7.0, 20% (v/v) glycerol, 4% (w/v) SDS, 0.01% (w/v) bromophenol blue 
and 100 mM DTT) and subjected to Western blot analysis, as previously described [8]. 
Briefly, samples containing 50 μg total protein were subjected to 7.5% (w/v) SDS-PAGE 
and transferred to nitrocellulose membranes. As a loading control, membranes were 
stained with Ponceau S solution (0.1% (w/v) Ponceau S in 5% (v/v) acetic acid) for 5 min 
followed by 2 washes in 5% (v/v) acetic acid. Membranes were then washed in Tris-
buffered saline (pH 7.4) containing 0.1% (v/v) Tween-20 (TBST), blocked for 1 h with 
5% (w/v) non-fat dry milk in TBST and incubated with rabbit anti-pro-TGF-β1/2/3 
(diluted 1:1,000 in TBST), rabbit anti-Smad2/3 antibody (diluted 1:1,000 in TBST) or 
rabbit anti-phospho-Smad2/3 antibody (diluted 1:1,000 in TBST) for 16 h at 4°C. 
Membranes were then washed in TBST and incubated with horseradish peroxidase-
conjugated goat anti-rabbit IgG antibody (1:2,000 dilution in TBST) at room temperature 
for 1 h. Protein bands were visualized using enhanced chemiluminescence reagent 
(Thermo Scientific) and detected on X-ray film. 
Immunofluorescence and brightfield microscopy 
Immunofluorescence microscopy was performed as previously described [8]. Briefly, 
ligated, deligated and contralateral control SMGs were snap frozen in 2-methylbutane 
cooled with liquid nitrogen. Glands were then equilibrated to -20°C, cut into 8 µm 
sections using a Leica CM1900 cryostat and adhered to microscope slides. Sections were 
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then fixed with 4% (v/v) paraformaldehyde in PBS, pH 7.4, for 20 min, washed three 
times in PBS and incubated in blocking buffer (5% (v/v) goat serum, 10 µM digitonin in 
PBS) for 2 h at room temperature. Sections were then incubated for 16 h at 4°C with 
rabbit primary antibodies specific for aquaporin-5, CD45, TGF-β R1, Smad2/3, phospho-
Smad2/3, Snail or E-cadherin (diluted 1:250 in blocking buffer). Primary antibody 
specificity for aquaporin-5 [44], CD45 [45], TGF-β R1 [46], Smad2/3 and phospho-
Smad2/3 [47], Snail [48] and E-cadherin [49] was determined, as cited, and sections 
incubated with only secondary antibody served as negative controls where no 
fluorescence was observed. Following three washes in PBS, sections were incubated with 
AlexaFluor 594 goat anti-rabbit IgG, AlexaFluor 488 goat anti-rabbit IgG or AlexaFluor 
594 goat anti-rat IgG (diluted 1:1,000 in blocking buffer) for 1 h at room temperature. 
Sections were then washed three times in PBS and stained with the nuclear dye Hoechst 
33258 (diluted 1:5,000 in PBS) for 5 min at room temperature. Following three washes in 
PBS, slides were mounted and dried. For dual-immunofluorescence analysis, goat serum 
in blocking buffer was replaced with donkey serum and, following a 2 h incubation in 
blocking buffer, SMG sections were treated with goat anti-aquaporin-5 antibody (diluted 
1:250 in blocking buffer) and the indicated rabbit primary antibody for 16 h at 4°C. Then, 
AlexaFluor 594 donkey anti-rabbit IgG and AlexaFluor 488 donkey anti-goat IgG 
secondary antibodies (both diluted 1:1000 in blocking buffer) were added to washed 
sections for 1 h at room temperature. Fluorescence was visualized using a Nikon Ti-E 
inverted microscope equipped with appropriate filters. 
For brightfield microscopy, ligated, deligated and contralateral control SMGs were 
placed in 4% (v/v) paraformaldehyde in PBS at 4°C for 24 h followed by 70% (v/v) 
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ethanol for 24 h at 4°C. Samples were then sent to IDEXX RADIL (Columbia, MO) 
where glands were embedded in paraffin, cut into 5 μm sections and subjected to 
hematoxylin and eosin or Masson’s trichrome staining. Hematoxylin and eosin-stained 
slides were visualized on an AMG EVOS XL Core brightfield microscope and Masson’s 
trichrome-stained slides were visualized on an Olympus Vanox AHBT3 brightfield 
microscope at the University of Missouri Molecular Cytology Core Facility. Low 
magnification images of whole SMG sections were generated from multiple 4X 
magnification images stitched together with Leica LAS3.1 imaging software. 
Statistical analysis 
Quantitative results are presented as means ± S.E.M. of data from three or more 
independent experiments. Statistical significance was defined as P<0.05 as calculated by 
one-way ANOVA with repeated measures post-test where appropriate or by a two tailed 
t-test, using GraphPad Prism software. 
Results 
Regeneration of duct-ligated SMG following deligation 
The SMG excretory duct ligation/deligation model has long been used for the study of 
salivary gland inflammation and regeneration [8–10, 14]. The SMG is composed 
primarily of ductal and acinar cells that can easily be distinguished by morphology and/or 
expression of cell-specific markers (Fig. Appendix II-1). Following 7 days of SMG duct 
ligation, expression of the acinar cell marker aquaporin-5 (AQP5), an apical membrane 
water channel, is dramatically reduced as acinar cells atrophy (Fig . Appendix II-1A vs. 
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1B) [17, 50]. Additionally, SMG duct ligation leads to enhanced immune cell infiltration, 
as judged by expression of the pan-immune cell marker CD45 (Fig . Appendix II-1E) [8, 
10], and the loss of ductal secretory granules (Fig . Appendix II-1H). Once the SMG 
excretory duct is deligated the gland begins to regenerate and, after a 28 day recovery 
period, expression of the acinar cell marker AQP5 returns to levels (Fig. Appendix II-1C) 
comparable to control glands (Fig. Appendix II-1A). Additionally, the number of immune 
cells returns to levels (Fig . Appendix II-F) comparable to control glands (Fig. Appendix 
II-1D). Ductal secretory granules also return after deligation (Fig. Appendix II-1I) and 
duct morphology resembles unligated control glands (Fig. Appendix II-1G). 
Reversible upregulation of TGF-β isoforms and TGF-β R1 occurs in the SMG 
following excretory duct ligation and deligation 
TGF-β signaling has been shown to regulate tissue fibrosis and regeneration in a number 
of tissues including liver, lung and kidney [22–25]. However, a role for TGF-β signaling 
in response to SMG duct ligation and deligation has not been defined. Western analysis 
using an antibody that recognizes all three TGF-β isoforms shows substantial TGF-β 
upregulation in response to a 7 day duct ligation. After duct deligation and a 28 day 
recovery, the levels of pro-TGF-β1/2/3 return to levels comparable to control glands (Fig. 
Appendix II- 2A). RT-PCR analysis of cDNA prepared from whole SMGs shows that 
expression of mRNA to TGF-β1 and TGF-β3, but not TGF-β2, is significantly increased 
in the SMG following 7 days of duct ligation, as compared to control glands (Fig. 
Appendix II-2B). Furthermore, TGF-β1 and TGF-β3 upregulation in response to duct 
ligation was fully reversible upon duct deligation and a 28 day recovery period, where 
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expression levels of these cytokines returned to control levels (Fig. Appendix II- 2B). In 
addition to TGF-β1 and TGF-β3, TGF-β R1 expression was significantly increased 
following SMG duct ligation, as compared to control glands, and returned to control 
levels 28 days after deligation (Fig. Appendix II- 2C). Dual-immunofluorescence staining 
of TGF-β R1 and the acinar marker AQP5 revealed that the expression of TGF-β R1 in 
the ligated SMG was restricted to acinar cells, similar to control glands. 
Reversible upregulation of canonical and non-canonical TGF-β signaling pathways 
in response to excretory duct ligation and deligation 
Canonical TGF-β signaling occurs following the binding of TGF-β to its cognate receptor 
to induce the phosphorylation and activation of the intracellular transcription factors 
Smad2 and Smad3, which then translocate to the nucleus to activate downstream targets 
of the TGF-β signaling cascade [30, 51]. Utilizing an antibody that recognizes both 
Smad2 and Smad3, Western analysis indicates that the expression of Smad2/3 in whole 
gland lysates from control SMGs is highly upregulated following 7 days of duct ligation 
(Fig. Appendix II- 3A). The level of Smad2/3 activation, as measured by the amount of 
phosphorylated-Smad2/3 (p-Smad2/3) in whole gland lysates, was also highly increased 
following SMG duct ligation (Fig. Appendix II- 3A). After duct deligation and a 28 day 
recovery, the levels of Smad2/3 and p-Smad2/3 return to levels comparable to control 
glands (Fig. Appendix II- 3A). Immunofluorescence analysis revealed that the increased 
expression of Smad2/3 (Fig. Appendix II- 3B) and p-Smad2/3 (Fig. Appendix II- 3C) 
induced by SMG duct ligation is localized to acinar cells, a response that was reversed 
upon deligation and a 28 day recovery (Fig. Appendix II- 3B and 3C), similar to TGF-β 
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R1 expression patterns (Fig. Appendix II- 2B). Dual-immunofluorescence staining of p-
Smad2/3 and AQP5 revealed that the expression of p-Smad2/3 following a 7 day duct 
ligation colocalized with Hoechst nuclear stain in acinar cells (Fig. Appendix II- 3C). 
In addition to canonical signaling through the activation of Smad transcription factors, 
non-canonical TGF-β signaling occurs through the activation of the mitogen-activated 
protein kinase-3 (MAP3K) TAK1 and the TAK1-binding protein TAB1 [52]. RT-PCR 
analysis reveals significant upregulation of both TAK1 and TAB1 mRNA expression 
following 7 days of SMG duct ligation and expression returned to levels comparable to 
unligated control glands following deligation and a 28 day recovery (Fig. Appendix II- 
3D). 
Reversible upregulation of Snail and Slug in response to duct ligation and deligation 
Smad2/3 phosphorylation and translocation to the nucleus mediates TGF-β-induced 
cellular responses through transcriptional activation of other DNA-binding transcription 
factors, including Snail (Snai1) and Slug (Snai2) [53]. The transcription repressor Snail is 
a primary target for regulation through direct binding of Smad2/3 to the Snail promoter 
[54, 55]. Following 7 days of SMG duct ligation, both Snail and Slug mRNA expression 
in whole SMGs was significantly increased, as compared to control glands, and 
expression was reversed to control levels after ductal deligation and a 28 day recovery 
(Fig. Appendix II- 4A and 4B). Immunofluorescence analysis of Snail localization 
following SMG duct ligation and deligation revealed a similar pattern to Smad2/3 and 
TGF-β R1, with Snail upregulation primarily restricted to acinar cells (Fig. Appendix II- 
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4C). Dual-immunofluorescence analysis confirmed the colocalization of Snail and AQP5 
following a 7 day duct ligation (Fig. Appendix II- 4D). 
Reversible upregulation of E-cadherin in response to SMG duct ligation and 
deligation 
Previous reports have described a role for TGF-β in EMT and Snail has been shown to be 
a primary effector in this pathway by repressing E-cadherin expression [32, 41]. Because 
our data show that upregulation of the transcriptional repressor Snail occurs after SMG 
duct ligation (Fig. Appendix II- 4) and E-cadherin expression is suppressed by Snail 
during EMT [32], we investigated whether E-cadherin expression is altered in response to 
SMG ligation and deligation. Interestingly, following 7 days of duct ligation, E-cadherin 
mRNA expression was significantly upregulated (Fig. Appendix II- 5A), despite the 
finding that TGF-β signaling molecules and Snail expression were increased following 
SMG duct ligation (Figs. Appendix II- 2–4). Immunofluorescence analysis of E-cadherin 
localization after SMG duct ligation revealed that E-cadherin was highly upregulated in 
ductal cells, suggesting that ductal cells maintain epithelial integrity (Fig. Appendix II- 
5B). It seems likely that upregulation of E-cadherin in ductal cells (Fig. Appendix II- 5B) 
is responsible for the overall upregulation of E-cadherin in whole gland cell lysates (Fig. 
Appendix II- 5A). Following deligation and a 28 day recovery, the expression of E-
cadherin returned to levels comparable to control glands (Fig. Appendix II- 5A and 5B). 
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Glandular fibrosis resulting from SMG duct ligation is resolved following ductal 
deligation 
Previous studies have demonstrated that SMG duct ligation can increase collagen 
deposition and glandular fibrosis [20]. Additionally, conditional overexpression of TGF-
β1 in the salivary glands leads to glandular fibrosis [56]. To investigate fibrosis 
progression and resolution in the murine duct ligation/deligation model, SMG ducts were 
ligated for 7 days followed by deligation and a 28 day recovery. After 7 days of duct 
ligation, collagen deposition assayed by Masson’s Trichrome staining (blue) was 
substantially increased around blood vessels and large collecting ducts of SMG as well as 
within the interlobular stroma (Fig. Appendix II-6B), as compared to control SMG (Fig. 
Appendix II-6A). Analysis at higher magnification revealed that duct ligation also caused 
extensive collagen deposition in the interstitial areas around acinar cells and ductal cells 
(Fig. Appendix II-6E), as compared to control SMG (Fig. Appendix II-6D), suggesting 
that active extracellular matrix (ECM) production and deposition occurred in these 
regions of the SMG. Following ductal deligation and a 28 day recovery (Fig. Appendix 
II-6C and 6F), glandular fibrosis was resolved and collagen deposition around blood 
vessels, collecting ducts and interstitial areas resembled control glands (Fig. Appendix II-
6A and 6D). RT-PCR analysis of cDNA prepared from whole SMGs revealed significant 
upregulation of collagen 1 and fibronectin mRNA after a 7 day duct ligation that returned 
to control levels after deligation and a 28 day recovery (Fig. Appendix II-6G). 
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Treatment with TGF-β R1 inhibitors attenuates upregulation of fibrosis markers in 
response to SMG duct ligation 
The small molecule TGF-β R1 inhibitors SB431542 and GW788388 have been shown to 
reduce TGF-β-mediated signaling and tissue fibrosis in mouse models of kidney, liver 
and lung fibrosis [57–60]. To determine whether TGF-β R1 inhibition reduces 7 day duct 
ligation-induced SMG fibrosis, mice were treated with SB431542 (20 mg/kg mouse 
weight), GW788388 (2 mg/kg mouse weight) or DMSO directly after SMG duct ligation 
and on day 4 post-ligation. RT-PCR analysis of 7 day ligated and contralateral unligated 
glands revealed significant attenuation of duct ligation-induced collagen 1 and fibronectin 
mRNA upregulation following treatment with either SB431542 or GW788388, as 
compared to DMSO-treated ligated glands (Fig. Appendix II- 7). 
Discussion 
TGF-β participates in diverse biological processes including development, inflammation, 
fibrosis, tissue regeneration and EMT [23, 25, 41, 61, 62]. In salivary glands, previous 
studies have shown that TGF-β isoforms can modulate branching morphogenesis during 
salivary gland development [63]. Additionally, in vitro studies have shown that TGF-β 
signaling modulates the formation of acinar units by primary murine SMG cells and the 
human salivary gland (HSG) cell line [64, 65], suggesting that TGF-β plays a role in 
regeneration of salivary acini in vivo. Overexpression of TGF-β1 in murine salivary 
glands has been shown to significantly disrupt salivary gland development and function, 
likely due to glandular atrophy and fibrosis [56]. Conversely, inhibition of TGF-β 
signaling in the salivary gland through conditional knockout of TGF-β R1 also leads to 
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salivary dysfunction through the development of multifocal lymphocytic inflammation of 
the salivary glands [66]. Global knockout of TGF-β1 in mice leads to a severe 
inflammatory phenotype characterized by lymphocytic infiltration of the heart, lung and 
salivary glands and premature death within 4 weeks of age [67]. Further investigation has 
revealed that TGF-β1-/- mice develop nuclear autoantibodies, glandular atrophy, loss of 
acinar cells and significant inflammatory lesions in the salivary gland, all of which are 
traits similar to the human autoimmune disorder Sjögren’s syndrome [68, 69]. While 
attempts to determine TGF-β levels in salivary glands of SS patients have yielded 
conflicting data [70, 71], studies have shown that TGF-β expression increases in patients 
suffering from chronic obstructive sialadenitis, a human condition caused by obstruction 
of the SMG excretory duct [72, 73]. Because the rodent model of SMG duct ligation 
closely mimics obstructive sialadenitis [74], the findings presented in this paper have 
clinical relevance. 
Tissue fibrosis is typically associated with chronic inflammation where molecular signals 
from unrepaired injured tissue stimulate resident fibroblasts, epithelial cells (through 
EMT) or bone marrow-derived fibrocytes to differentiate into myofibroblasts [75, 76]. 
Overproduction and deposition of ECM components, such as collagen 1 and fibronectin, 
progressively replace normal parenchyma and disrupt tissue morphology and function 
[75]. In vitro studies have shown that TGF-β stimulates the production of collagen and 
fibronectin, key proteins in the development of fibrosis [77, 78]. In vivo, TGF-β also has 
been shown to stimulate fibrogenesis in animal models of liver, lung and kidney fibrosis 
[79–81]. Salivary gland fibrosis following radiation exposure during treatment of head 
and neck cancers contributes to long term hyposalivation in patients [82, 83] and 
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increased TGF-β expression has been reported in patients suffering from radiation-
induced xerostomia [84]. Additionally, TGF-β has been shown to initiate fibrosis 
following radiation treatment of the skin [85], suggesting that TGF-β may contribute to 
radiation-induced salivary gland fibrosis. The results from this study show that significant 
collagen deposition and upregulation of collagen 1 and fibronectin mRNA (Figs. 
Appendix II- 6–7) in the SMG following duct ligation occurs concurrently with increased 
expression of TGF-β signaling components (Figs. Appendix II-2–4). Moreover, ligation-
induced SMG fibrosis is attenuated following administration of the TGF-β R1 inhibitors 
SB431542 and GW788388 (Fig. Appendix II-7). These small molecule TGF-β R1 
inhibitors have been shown to inhibit TGF-β signaling through competitive antagonism 
of TGF-β R1 kinase activity, thereby preventing phosphorylation and activation of Smad 
transcription factors [86, 87] suggesting that this canonical TGF-β signaling pathway 
plays a major role in duct-ligation induced fibrosis. The remarkable ability of the duct-
ligated SMG to regenerate following deligation makes this an ideal model to investigate 
the molecular pathways involved in fibrosis resolution. Identifying mechanisms that 
modulate the expression or function of proteins which aid in fibrosis resolution (i.e., 
matrix metalloproteases (MMPs), tissue inhibitors of metalloproteases (TIMPs) and 
hepatocyte growth factor (HGF) [88–90]) in the murine duct-ligated SMG could help 
develop strategies to reduce salivary gland fibrosis in humans that occurs in chronic 
obstructive sialadenitis or following radiation treatment for head and neck cancer. 
In addition to its role in stimulating myofibroblasts during fibrosis, TGF-β has significant 
effects on epithelial cells. TGF-β signaling in epithelial cells has been shown to induce 
migration, reduce proliferation and stimulate apoptosis [91–93]. Interestingly, the data 
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presented in this paper suggest that TGF-β signaling is very active in salivary acinar cells 
during duct ligation (Figs. Appendix II-2–4). Previous studies have demonstrated the 
presence of TGF-β in saliva where it is hypothesized to function in maintaining immune 
homeostasis in the oral cavity and esophagus [94, 95]. Furthermore, 
immunohistochemical studies have shown that TGF-β is localized to ductal cells in the 
salivary glands of humans and mice under normal and pathological circumstances [65, 
70, 71]. Our data suggest that TGF-β R1 is primarily expressed in salivary acinar cells 
(Fig. Appendix II-2C) and these cells also demonstrate upregulation of molecules in the 
TGF-β signaling cascade following ductal ligation (Figs. Appendix II-3 and 4). Perhaps 
ductal cells secrete TGF-β during normal salivary gland function which then accumulates 
in the lumen after the gland is ligated, whereupon elevated TGF-β levels activate the 
upregulated TGF-β R1 on salivary acinar cells. Previous studies have shown that some 
subsets of ductal cells proliferate in response to SMG duct ligation while acinar cells 
downregulate expression of AQP5 and eventually undergo apoptosis [11, 15, 19]. Thus, 
the altered expression of TGF-β R1 in salivary acinar cells may be a contributing factor 
to the known responses of salivary epithelium to SMG duct ligation. 
The ability of TGF-β to induce the transition of epithelial cells into a mesenchymal 
phenotype has been extensively studied both in vitro [41, 65, 96–99] and in vivo [100–
104], and is widely regarded as a necessary process in embryogenesis [105]. However, 
the in vivo significance of post-embryogenesis EMT has been debated [106–108]. In 
exocrine glands, EMT has been shown to play a role in the repair of lacrimal glands 
following IL-1-induced injury [109] and, in the pancreas, EMT induces the formation of 
insulin-secreting beta cells from pancreatic acinar cells [110, 111]. Other studies have 
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provided in vivo evidence of TGF-β-induced EMT in the kidney, liver and lungs [100, 
103, 104]. During EMT, epithelial cells downregulate the expression of proteins 
necessary for epithelial function, such as the cell adhesion molecule E-cadherin and the 
tight junction proteins ZO-1 and claudin, and upregulate proteins that contribute to 
mesenchymal function, such as the intermediate fiber vimentin and α-smooth muscle 
actin [37, 41]. TGF-β induces EMT through the phosphorylation and activation of Smad 
family transcription factors that then induce the upregulation of other transcriptional 
regulators, such as the zinc-finger transcription repressors Snail and Slug [32, 33, 54]. 
Snail is a well-described repressor of E-cadherin expression [32, 42, 43] and 
overexpression of Snail induces EMT in several types of epithelial cells [32]. TGF-β-
induced TAK1 activation, which is thought to occur through TAK1/TAB1 interaction 
with TNF receptor-associated factor 6 (TRAF6) and downstream NF-κB activation, has 
been shown to regulate EMT in both human lung epithelial and peritoneal-derived 
mesothelial cells [35, 36, 112]. Our results show increased Smad2/3 and TAK1/TAB1 
expression (Fig. Appendix II-3) as well as upregulation of Snail and Slug expression 
following ductal ligation (Fig. Appendix II-4), which suggests that TGF-β signaling is 
increased in salivary epithelial cells during injury. Of particular interest is the differential 
expression pattern of Snail in response to duct ligation where ductal cells appear to have 
low expression levels of Snail, whereas acinar cells have much higher expression levels 
(Fig. Appendix II-4C and 4D). This acinar localization of Snail is in agreement with 
Smad2/3 localization (Fig. Appendix II-3B and 3C), both of which are likely the result of 
the upregulation and localization of TGF-β R1 in acinar cells caused by SMG duct 
ligation (Fig. Appendix II-2C). If TGF-β-induced EMT occurs in duct-ligated SMG, one 
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would expect to find E-cadherin downregulation in the gland [32]. However, our results 
show significant upregulation of E-cadherin following a 7 day SMG duct ligation (Fig. 
Appendix II-5A). It seems likely that upregulation of E-cadherin in ductal and not acinar 
cells (Fig. Appendix II-5B) is responsible for the overall upregulation of E-cadherin in 
whole gland cell lysates (Fig. Appendix II-5A). Interestingly, previous studies have 
shown that E-cadherin expression increases in kidney tubules following ureteral ligation 
[113]. Taken together, these data suggest that during SMG duct ligation, salivary 
epithelium (acinar and ductal cells) have diverse responses which could be driven in part 
by differential capacities for TGF-β signaling. Whereas salivary acinar cells upon SMG 
duct ligation exhibit decreased expression of AQP5 (Fig. Appendix II-1) [17] and cellular 
atrophy (Fig. Appendix II-1) [50] and increased expression of TGF-β signaling molecules 
(Figs. Appendix II-2–4), ductal cells exhibit increased E-cadherin expression (Fig. 
Appendix II-5) and proliferation [18, 19]. Perhaps the increase in E-cadherin expression 
in ductal cells is a protective response. Previous studies have demonstrated a role for E-
cadherin in cell survival, where conditional knockout of E-cadherin in alveolar epithelial 
cells in the mammary gland led to significant apoptosis and glandular dysfunction [114, 
115]. Whether salivary acinar cells actually undergo EMT during duct ligation remains to 
be determined, however, it seems likely that TGF-β signaling contributes to the observed 
changes in acinar cell morphology that occur upon duct ligation. 
The results from this study provide evidence of a role for TGF-β during mature salivary 
gland damage and regeneration. We show significant upregulation of TGF-β1 and TGF-
β3 as well as TGF-β R1 in response to SMG duct ligation (Fig. Appendix II-2). 
Furthermore, we provide evidence for active TGF-β signaling in salivary acinar epithelial 
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cells caused by duct ligation, as indicated by increases in the expression and 
phosphorylation of Smad2/3 and the expression of its downstream target Snail (Figs. 
Appendix II-3 and 4). This study also provides evidence that SMG duct ligation causes 
fibrosis (Fig. Appendix II-6), concurrent with enhanced TGF-β signaling in acinar cells 
(Figs. Appendix II-2–4) that can be attenuated following administration of small 
molecule TGF-β R1 inhibitors (Fig. Appendix II-7). We also describe the reversibility of 
these cellular responses upon ductal deligation and recovery, thereby demonstrating the 
capacity of the SMG to regenerate following damage and fibrosis. Although it has 
classically been used to study inflammatory and regenerative pathways, SMG duct 
ligation-induced damage appears to be an ideal model for investigating mechanisms that 
initiate and resolve salivary gland fibrosis. The observed differential responses of salivary 
acinar and ductal cells to TGF-β also indicate that this model should be useful for in vivo 
studies of TGF-β signaling in epithelial cells. Further insights into TGF-β signaling in 
duct-ligated SMG could identify novel therapeutic targets for salivary gland fibrosis 
associated with obstructive sialoadenitis and radiation-induced damage to the salivary 
gland in humans. 
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Figures 
Fig. Appendix II-1. Submandibular gland ductal ligation followed by deligation 
results in reversible acinar cell atrophy, immune cell infiltration and glandular 
fibrosis.  (A, D, G) Control SMG, (B, E, H) 7 day duct-ligated SMG and (C, F, I) 7 day 
duct-ligated SMG followed by deligation and recovery for 28 days were subjected to 
immunofluorescence staining with (A-C) antibodies to the acinar cell marker AQP5 
(green) and Hoechst nuclear stain (blue), (D-F) antibodies to the pan-immune cell marker 
CD45 (red) and Hoechst nuclear stain (blue) and (G-I) hematoxylin and eosin. Results 
indicate that ligation of the main SMG excretory duct induces (B) loss of acinar cells, (E) 
substantial immune cell infiltration and (H) atrophy of acinar cells (white arrow) and loss 
of secretory granules (pink) within ductal cells (black arrow) that is reversed by 
subsequent deligation (C, F, I). Images are representative of results from at least 3 
independent experiments and scale bar = 20 µm. 
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Fig. Appendix II-2. Upregulation of TGF-β1, TGF-β3 and TGF-β R1 in response to 
SMG duct ligation is reversible upon deligation. (A) Western analysis of whole gland 
lysates shows upregulation of pro-TGF-β1/2/3 expression (top) in response to 7 day SMG 
duct ligation that is reversible following deligation and recovery for 28 days. Ponceau S 
staining (bottom) shows equal amounts of total protein in each well. (B) RT-PCR 
analysis of cDNA prepared from whole SMGs shows significant upregulation of TGF-β1 
and TGF-β3, but not TGF-β2, mRNA expression after 7 days of SMG excretory duct 
ligation (grey bars), as compared to contralateral control glands (white bars). When ducts 
were ligated for 7 days then deligated for 28 days (black bars), expression levels of TGF-
β1 and TGF-β3 mRNA return to control levels, whereas TGF-β2 mRNA levels remain 
unchanged. Data represent means ± S.E.M. (n = 7 for control and 7 day ligation, n = 5 for 
7 day ligation, deligation and a 28 day recovery), where *P < 0.05 and **P < 0.01 
indicate significant differences in mRNA expression, as compared to control. (C) Dual-
immunofluorescence analysis of 8 µm frozen SMG sections for control, 7 day ligation 
and 7 day ligation followed by deligation and recovery for 28 days reveals that TGF-β R1 
(red) expression is upregulated primarily in acinar cells (marked by residual AQP5 
expression; green) after a 7 day SMG duct ligation, whereas little staining is visible in 
ductal cells. After a 7 day duct ligation followed by deligation and a 28 day recovery, 
TGF-β R1 expression levels are similar to control. Hoechst nuclear stain in blue and scale 
bar = 20 µm. Images are representative of results from at least 3 independent 
experiments. 
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Fig. Appendix II-3. Upregulation of Smad2/3, TAK1 and TAB1 in response to SMG 
duct ligation is reversible upon duct deligation. (A) Western blot analysis of whole 
gland lysates from unligated control SMG, SMG after a 7 day duct ligation or a 7 day 
ligation followed by deligation and a 28 day recovery.  Duct ligation increases Smad2/3 
expression (top) and phospho-Smad2/3 levels (middle) that return to control levels after 
deligation and recovery. Ponceau S staining (bottom) shows equal amounts of total 
protein in each well. Immunofluorescence analysis revealed that increases in (B) 
Smad2/3 (red) expression and (C) p-Smad2/3 (red) levels after a 7 day duct ligation are 
restricted to acinar cells (marked by residual AQP5 expression; green), where p-Smad2/3 
is localized to the nucleus, as determined by colocalization with Hoechst nuclear stain 
(blue). Smad2/3 and p-Smad2/3 returned to control levels after deligation of SMG ducts 
and recovery. Images are representative of results from at least 3 independent 
experiments and scale bar = 20 µm. (D) RT-PCR analysis of whole gland lysates shows 
increased TAK1 and TAB1 mRNA expression following a 7 day duct ligation, which was 
reversed to control levels following deligation and a 28 day recovery. Data represent 
means ± S.E.M. (n = 6 for control, n = 8 for 7 day ligation, n = 5 for 7 day ligation, 
deligation and a 28 day recovery), where *P < 0.05 and **P < 0.01 indicate significant 
differences in mRNA expression, as compared to control SMG. 
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Fig. Appendix II-4. Upregulation of Snail and Slug in response to SMG duct ligation 
is reversible upon duct deligation. RT-PCR analysis of cDNA prepared from whole 
SMGs shows significant upregulation of (A) Snail and (B) Slug mRNA after a 7 day duct 
ligation, which is reversed to control levels after deligation and a 28 day recovery. Data 
represent means ± S.E.M. (n = 4 for control, n = 8 for 7 day ligation, n = 5 for 7 day 
ligation, deligation and a 28 day recovery), where ***P < 0.001 and *P < 0.05 indicate 
significant differences in mRNA expression, as compared to control SMG. (C)  
Immunofluorescence analysis reveals that Snail (red) expression is primarily upregulated 
in acinar cells after a 7 day duct ligation, and returns to control levels after deligation and 
recovery. (D) Dual-immunofluorescence staining confirmed the colocalization of Snail 
(red) with the acinar marker AQP5 (green) following a 7 day duct ligation. Hoechst 
nuclear stain in blue and scale bar = 20 µm.  Images are representative of results from at 
least 3 independent experiments. 
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Fig. Appendix II-5. E-cadherin upregulation in response to SMG duct ligation is 
reversible after duct deligation. (A) RT-PCR analysis of cDNA prepared from whole 
SMGs shows significant upregulation of E-cadherin mRNA after a 7 day duct ligation 
(grey bar), which is reversed to control levels (white bar) after deligation and a 28 day 
recovery (black bar). Data represent means ± S.E.M. (n = 8 for control, n = 7 for 7 day 
ligation, n = 5 for 7 day ligation, deligation and a 28 day recovery), where ***P < 0.001 
indicates a significant difference in mRNA expression, as compared to control SMG. (B) 
Immunofluorescence analysis reveals that E-cadherin (red) was significantly upregulated 
in SMG ducts after a 7 day ligation, and returned to control levels after deligation and 
recovery. Hoechst nuclear stain in blue and scale bar = 20 µm. Images are representative 
of results from at least 3 independent experiments. 
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Fig. Appendix II-6. Glandular fibrosis following SMG duct ligation is resolved 
following deligation. SMGs from unligated controls (A, D), after a 7 day duct ligation 
(B, E) or a 7 day ligation followed by deligation and a 28 day recovery (C, F) were 
subjected to Masson’s trichrome staining to analyze collagen deposition (blue). A 7 day 
duct ligation resulted in blue staining of collagen fibers around blood vessels and large 
saliva collecting ducts (B), as compared to controls (A). At 400X magnification, heavy 
deposition of collagen fibers can be seen in the interstitial area around acinar and ductal 
cells after a 7 day duct ligation (E), as compared to controls (D). Following ductal 
deligation and a 28 day recovery (C, F), collagen deposition returns to levels similar to 
control SMGs (A, D). Images are representative of results from at least 3 independent 
experiments. (A-C) scale bar = 1,000 µm, (D-F) scale bar = 20 µm. (G) RT-PCR analysis 
of cDNA prepared from whole SMGs shows extensive upregulation of collagen 1 and 
fibronectin mRNAs after a 7 day duct ligation (grey bars), which is reversed to control 
levels (white bars) after deligation and a 28 day recovery (black bars). Data represent 
means ± S.E.M. (n = 8 for control, n = 7 for 7 day ligation, n = 5 for 7 day ligation, 
deligation and a 28 day recovery), where ***P < 0.001 indicates a significant difference 
in mRNA expression, as compared to control SMGs. 
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Fig. Appendix II-7. TGF-β R1 inhibitors SB431542 and GW788388 attenuate duct 
ligation-induced upregulation of fibrosis markers. RT-PCR analysis of 7 day ligated 
and contralateral unligated control SMGs shows significant attenuation of 7 day duct 
ligation-induced collagen 1 and fibronectin mRNA upregulation in mice treated with 
either SB431542 (20 mg/kg mouse weight) or GW788388 (2 mg/kg mouse weight), as 
compared to DMSO-treated controls. Data represent means ± S.E.M. (n = 6 for DMSO, n 
= 6 for SB431542, n = 5 for GW788388), where *P < 0.05 and ***P < 0.001 indicate 
significant differences in mRNA expression, as compared to DMSO-treated controls. 
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